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Pulmonary nodules are visible as dense, opaque areas in the lung on com-
puted tomography (CT) images and may be early indications of lung cancer.
Pulmonary nodule growth rate is highly correlated with malignancy and there-
fore its evaluation is useful in clinical decision making. Automated methods
have been developed for nodule growth rate measurements, but these methods
exhibit large measurement error; reducing this error will enable radiologists to
make better decisions regarding follow up and treatment, in turn improving
patient outcomes. Four major aspects of pulmonary nodule measurement are
addressed in this thesis.
A formal procedure for the comparative evaluation of different computer al-
gorithms for pulmonary nodule change measurement has been developed that
involves a standardized set of 50 CT image pairs and an analysis method. This
procedure for the first time addresses the need to be able to quantitatively com-
pare the performance of different methods. A study has been conducted in
which developers of 18 computer methods participated and the results form
a baseline with which to compare current and future algorithms.
Two different computer algorithm approaches were developed to reduce the
uncertainty in growth rate measurements. The first approach, moment-based
compensation (ZCOMP) was performed on segmented nodule images to ad-
dress additional observed increased error in the z-direction compared to the xy-
plane. By applying ZCOMP, volumetric measurement variability was reduced
from a 95% limits of agreement of (-24.0%, 18.2%) to (-12.4%, 12.7%) on zero-
change nodules imaged on thin-slice scans of the same resolution. The second
approach was developed to address difficult-to-segment nodules with complex
shapes and attachments. Instead of explicitly segmenting the nodule from the
lung parenchyma, the growth index from density method (GID) uses the density
change in a region of interest as a surrogate growth measure. The GID method
had much lower variation, (-11.0%, 12.3%) compared to a volumetric segmenta-
tion method, (-25.2%, 18.6%).
Finally, an automated method was developed for measuring murine pul-
monary nodule growth from micro-CT scans, adapting work from methods de-
veloped for human patients. This provides improved accuracy for lesion growth
measurements used in small animal pre-clinical studies. The method addresses
the additional noise, lack of contrast, and poor calibration of micro-CT scans.
The measured growth rate was compared to the exponential growth model, and
on a dataset of six nodules with repeat scans, the method measured growth that
was consistent with the model.
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CHAPTER 1
INTRODUCTION
Radiologists consider the growth rate of a lesion as a major factor when de-
ciding the suspicion for cancer and whether follow-up with the patient is neces-
sary, and if so, what follow-up should be performed [1, 2]. The follow-up might
range from having another visit in a year, a visit in a month, chemotherapy, or
surgery to remove a cancer. Accurately measuring the growth of suspicious le-
sions is critical for improving the accuracy of diagnoses and, in turn, the quality
of patient care.
While growth rate is relevant to all cancer types, lung cancer is of prime im-
portance, since it is the leading cause of cancer death in both men and women,
accounting for approximately 28% of all cancer deaths in 2012, according to
the American Cancer Society [3]. The high contrast of pulmonary nodules seen
in computed tomography (CT) images makes them highly suitable for quanti-
tative imaging methods. Several methods and analyses have been developed
to improve the accuracy and reliability of growth measurements of pulmonary
nodules, the earliest manifestations of lung cancer, from CT scans of the lung.
In this thesis, the following facets of growth measurement have been addressed:
• The creation of an analysis methodology and a related landmark image
dataset to facilitate the relative performance of different pulmonary nod-
ule measurement methods (Chapter 2).
• The development of computer algorithms to reduce the measurement er-
ror for CT scanners that exhibit anisotropic geometric distortion (Chapter
3).
• Developing density-based methods that provide useful measurements on
complex nodules for which conventional geometric-based methods fail
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(Chapter 4).
• Extending automated pulmonary nodule growth measurement methods
to pre-clinical studies with mouse models imaged with micro-CT and val-
idating the exponential growth rate model with this technique (Chapter
5).
The remainder of this chapter provides a background of lung cancer and out-
lines the issues in pulmonary lesion measurement.
1.1 Lung cancer diagnosis and monitoring
Lung cancer, a disease characterized by the uncontrolled growth and spread of
abnormal cells in the lung, accounts for more cancer-related deaths than any
other cancer in both men and women, more than prostate, breast, and colon
cancer combined. If the cancer can be identified while it is still localized, the
5-year survival rate is 52%, compared to 16% for all stages of lung cancer; how-
ever, only 15% of lung cancers are currently detected at the early stage [3]. In a
screening situation, the 10-year survival rate can be as high as 92% [4].
To diagnose lung cancer, radiologists image the patient using either chest x-
ray or computed tomography (CT) in order to view structures within the lung.
Two major studies have shown the effectiveness of CT screening for lung can-
cer. A large screening study of 31,567 asymptotic patients by the International
Early Lung Cancer Action Program found lung cancer in 484 participants [4]. Of
these, 412 (85%) had early stage (clinical stage I) cancer with an estimated 10-
year survival rate of 88%. The 302 patients with stage I cancer who were treated
via surgical resection within a month of diagnosis had an improved survival
rate of 92%, while the patients that did not receive treatment died within five
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years. A study sponsored by the National Cancer Institute with about 53,500
enrolled participants compared the efficacy of CT with chest X-ray and found
a 20.3% reduction in deaths for those participants screened using CT compared
with X-ray (354 versus 442 deaths for CT screening and x-ray screening respec-
tively) [5].
To make a diagnosis from a CT image, radiologists examine the CT images
to find nodules and then analyze the nodule’s size, density, and growth rate to
determine the course of action for the patient [6]. Large nodules, those greater
than 25 or 30 mm, require immediate attention, usually in the form of a biopsy.
Generally, small nodules less than 4 mm pose a low risk of malignancy and only
require a follow-up scan in a year. For nodules of intermediate size between 5
mm and 25 mm, follow-up scans are often suggested. Based on these follow-up
scans, the growth rate can be measured and nodules with a high growth rate
will be referred for either additional CT scans, positron emission tomography
scans, or biopsy [6, 7], though there are some differences among authors on the
exact cutoff sizes, the growth threshold, and the follow-up scan interval.
In addition to diagnosing lung cancer, the growth rate of nodules may be
used to monitor the response to therapy [8]. There have been attempts at de-
veloping consistent guidelines to determine whether a nodule is responding
to treatment; one of the most widely used is the response evaluation criteria
in solid tumors (RECIST) [9]. In the RECIST guidelines, measurable nodules
are those whose minimum size is 10 mm, with a maximum 5 mm CT slice
thickness—in RECIST, the size is defined as the longest diameter through the
nodule on the slice where the nodule has the largest appearance. The change in
size of all nodules is reported as one of the following categorical values. A com-
plete response requires all the target nodules to disappear. Partial response to
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therapy requires a 30% decrease in the sum of diameters for the target nodules,
while progressive disease requires a 20% increase in the sum of diameters, but
at least a 5 mm increase in size. Given a nodule that is 10 mm in diameter, par-
tial response to therapy would require the nodule size to decrease to 7 mm in
diameter, which is a decrease in volume of 66%, while an indication of progres-
sive disease would require the nodule to increase in size to 12 mm, or a volume
increase of 73%. Given a more reliable measure of size change, treatments could
be evaluated more quickly for effectiveness.
1.2 Computed tomography
One of the most important developments for diagnosing lung cancer was the
invention of the computed tomography (CT) scanner. CT scanners enable radi-
ologists to view internal body structures in three dimensions through the use of
an X-ray source and detector that are rotated around the body. The X-ray has the
capability to penetrate matter, but the radiation intensity decreases while going
through an object. The decrease in radiation is due to absorption and scattering
as the X-ray travels through the object, which is represented by Beer’s law of
attenuation:
I(η) = I0e−µη
which states that the intensity at distance η exponentially decreases from the ini-
tial intensity at distance 0, I0, with the attenuation coefficient µ [10, Chapter 2].
The attenuation coefficient is dependent upon the density and atomic weight of
the matter, which allows for the determination of density based on the observed
X-ray attenuation.
As the X-ray source is rotated around the body, multiple 2D X-ray projec-
tions are acquired. In first-generation CT scanners, a single, pencil-like X-ray
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beam would be emitted from the X-ray source, with a single detector placed
opposite the source. The source and detector were moved synchronously, ac-
quiring projections around the body. Modern CT scanners use a cone-shaped
beam with a multi-row detector array. This enables the sampling of multiple
sections (slices) of data per rotation of the source [11].
In early CT scanner designs, the source and detector would complete a full
rotation around the body, after which the table supporting the patient would
move, and the process would repeat until the full height (in the axial direction)
of the desired region was imaged. Acquisition was performed in this manner
due to the cabling connecting the source and detector, which would need to be
allowed to wind and unwind. The introduction of slip-ring technology replaced
the cables, allowing for continuous acquisition as the table moves, resulting in
spiral sampling [11]. The X-ray source and detector are mounted on a gantry,
and the ratio of the distance the table moves per rotation of the gantry to the
height of the X-ray beam is referred to as the pitch. A pitch of 1.0 represents a
linear motion of the table that is equivalent to the height of the X-ray beam [12].
A reconstruction algorithm takes these projections and forms a three-dimensional
image which is presented as a stack of image slices. Early CT scanners with
pencil-beam X-ray geometry used the inverse Radon transform to reconstruct
the CT image [13], but modern CT scanners, due to the use of cone-beam ge-
ometry, multi-row detectors and spiral acquisition, use much more complex 3D
algorithms that are described in detail by Buzug (2008) [14].
In each image slice, a pixel represents a small 3D volume and is typically
called a “voxel”. In the resulting CT images, the value of the voxel is related to
the density of the tissue; CT scanners are calibrated so that, on the Hounsfield
scale, a voxel value of 0 corresponds to water and -1000 to air [15]. Hounsfield
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units are defined by the following expression:
Htissue =
µtissue − µwater
µwater
× 1000
where µ are the linear attenuation coefficients to X-rays.
The quality of a CT scan depends upon several scanner parameters; for the
automated analysis of images considered in this work, the most important pa-
rameters are radiation dose, slice thickness, pitch, field of view, and reconstruc-
tion parameters. The radiation exposure from CT is a concern due to its use
of ionizing radiation, which may have harmful side effects such as cancer [16];
there is no consensus about how much radiation is a concern, only that radi-
ation exposure should be minimized. Higher radiation doses allow for better
quality images due to a higher signal to noise ratio, but this has to be balanced
against the desire to limit radiation to the patient.
The slice thickness specifies the width of each section along the axial direc-
tion of the scanner, which is determined by the speed of table movement, the
width of each detector, and the amount of overlap between detectors. Thinner
slice thickness scans have more detail than scans with thicker slice thickness,
but this comes with additional cost. The thinner slices result in more slices for
the same imaged volume, resulting in additional workload for the radiologist
to review more slices.
The pitch used for acquisition affects the scanning speed, radiation dose,
and image quality [12]. If all other parameters are fixed, increasing the pitch
will reduce the scanning time and either increase the effective slice thickness or
increase the image noise.
The field of view controls the in-plane size of each voxel. In a whole-lung
field of view, the entire lung is in view, resulting in an in-plane resolution of
about 0.6–0.8 mm per voxel. If the radiologist knows the location of the nodule,
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a scan with a targeted field of view can be acquired of just the region of interest.
These scans typically have an in-plane resolution of 0.18 mm. Although targeted
scans have a higher physical resolution, the location of the nodule needs to be
known, and thus are not useful for finding new nodules.
Finally, during reconstruction, different filters may be applied to enhance
the image; these filters differ primarily in the frequency-cutoff of the higher
spatial frequencies. An edge-enhancing filter emphasizes high spatial frequen-
cies, while a soft filter produces a smoother image by eliminating high spatial
frequencies [17].
1.2.1 Pulmonary nodules on CT
In its earliest manifestation, lung cancer often presents as a pulmonary nod-
ule; however, not all pulmonary nodules are malignant—some may be caused
by a variety of benign conditions such as inflammation of the airways. A pul-
monary nodule appears on a CT scan as a high intensity object within the lung
parenchyma which does not belong to any normal anatomical structures such
as vessels or airways, as shown in Figure 1.1.
Pulmonary nodules may be categorized according to their density and sur-
rounding attachments. Nodules with a high density, called “solid nodules”,
have an opaque appearance on CT scans, while nodules with a low density,
“non-solid nodules”, have a more ill-defined appearance. Nodules with both
solid and non-solid components are called “part-solid”. The term “subsolid”
is often used to refer to both non-solid and part-solid nodules. Examples of
these nodules are shown in Figure 1.2. In addition to exhibiting different densi-
ties, nodules may either be isolated in the lung parenchyma or attached to other
structures. Isolated nodules are not attached to any other high-intensity struc-
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(a) (b)
Figure 1.1: Small solid pulmonary nodule on a) single slice of a CT scan and b)
several slices of a CT scan in a small region of interest
tures and are the easiest nodules to segment. Attached nodules may be attached
to either blood vessels or airways, and juxtapleural nodules are attached to the
chest wall. Enlarged images of the central slices of isolated, juxtapleural, and
attached nodules are shown in Figure 1.3.
The majority of nodules found in a screening study are of the solid type; a
study by Henschke et al. (2002) found that 88.0% (205/233) of the 233 nodules
identified during baseline scans in their screening study were solid, while 12%
(28/233) were non-solid nodules [18]. A majority of the malignant nodules,
82.8% (24/29), were solid or part-solid.
1.2.2 CT image quality issues
While CT has some unique advantages compared to other imaging modalities,
it does have some flaws [19]. Due to the use of ionizing X-ray radiation, of-
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(a) (b) (c)
Figure 1.2: Examples of a) solid, b) part-solid, and c) non-solid nodules on a
single slice of a CT scan, with the nodule indicated by a white box. Images are
shown at different magnification levels.
(a) (b) (c)
Figure 1.3: Central slices of regions containing a) isolated, b) attached, and c)
juxtapleural nodules
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ten image quality is comprised in order to achieve a lower radiation dose. This
results in scans with additional noise compared to scans taken using a higher ra-
diation dose. The radiation is absorbed by all tissues in the body, which results
in another problem – photon starvation given the presence of a large amount of
dense (absorbing) tissue to penetrate, such as bone. The tissue absorbs many of
the photons, reducing the number of photons reaching the detectors resulting
in an increase in noise. This noise is magnified during the reconstruction pro-
cess, resulting in visible horizontal streaks in the image. Aside from tissue, the
presence of metal in the body, such as pace maker wires or spinal implants, may
also cause streaking artifacts due to the material’s extraordinarily high density
“Beam hardening” occurs when lower energy photons in an X-ray beam are
absorbed more readily as they pass through objects than higher energy pho-
tons. This effect increases the mean energy of the beam, resulting in streaking
artifacts. These streaking artifacts occur between two nearby dense objects in
an image. When the X-ray source is at a position where it passes through only a
single object, the beam is hardened less than when the beam has to pass through
both objects [19]. This occurs in bony areas of the body.
There are also artifacts caused by patient motion; if the patient moves, then
structures are at different places during different portions of the acquisition,
leading to misregistrations and artifacts in the reconstruction.
One of the most critical issues with respect to nodule growth measurement is
the partial volume averaging effect. At the borders of objects, a voxel may not be
completely filled with a single tissue type—at the edge of a pulmonary nodule,
a voxel is likely to partially contain a some nodule tissue and lung parenchyma.
This makes the edges of the nodule more difficult to discern, and this effect is
especially pronounced on the top and bottom of the nodule, where, the voxels
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(a) (b)
Figure 1.4: Example of a phantom nodule showing the edge blurring and lower
intensity due to the partial voxel effect on the a) top image slice. The b) center
slice is shown for comparison
on an entire slice may all be partial voxels. An example of this effect is shown in
Figure 1.4. This effect can be mitigated by performing scans at a higher resolu-
tion (in-plane), such as with a targeted scan, and by using thinner image slices.
1.3 Pulmonary growth rate measurement
The growth rate of pulmonary nodules is a key indicator of malignancy. The
most common method of measuring the growth rate is by measuring the size of
the nodule on at least two scans taken at different times, and using the change
in volume and interval between the scans to compute the growth rate [20].
The growth rate is often reported as the time it would take for the nodule to
double in size, which is termed doubling time (DT) and given by the following
11
expression:
DT =
ln 2 · ∆t
ln
(
V2
V1
)
where ∆t is the time interval in days between the two scans, V2 is the nodule size
measured on the second scan, and V1 is the nodule size measured on the first
scan. The doubling time expression is derived from the equation for exponential
growth:
V2 = V1 · eλ·∆t (1.1)
ln
(
V2
V1
)
= λ · ∆t (1.2)
This expression can be rearranged in two ways:
∆t =
ln
(
V2
V1
)
λ
(1.3)
λ =
ln
(
V2
V1
)
∆t
(1.4)
To compute doubling time, the size doubles, V2V1 = 2, and substituting into
Equation 1.3 results in:
DT =
ln 2
λ
(1.5)
and λ is obtained from Equation 1.4, which results in the final equation
DT =
ln 2 · ∆t
ln
(
V2
V1
) (1.6)
with the parameters described above. A higher growth rate results in a smaller
doubling time, and typically, a nodule with a doubling time of less than 400 days
is considered to be a malignant growth rate [21]. An alternative measurement of
growth rate is the growth index (GI). The growth index represents the percentage
increase in size per month computed using the expression
GI = 100 ·
[
(V2/V1)
30.4375/∆t − 1
]
(1.7)
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where V2, V1, and ∆t are the same as in the doubling time equation. The GI
expression is an exponential growth equation modified to produce a percentage
result, and larger values of GI indicate faster growth. GI can be converted to DT
and vice versa:
GI = 100
[
230.4375/DT − 1
]
(1.8)
DT =
30.4375 · ln 2
ln
( GI
100 + 1
) (1.9)
A doubling time of 400 days corresponds to a GI of 5.4%.
Thus, to measure the growth rate, the size change and time interval are re-
quired. The size change can be measured manually by radiologists or through
automated algorithms.
1.3.1 Manual pulmonary nodule measurement
Radiologists can measure nodules using a uni-dimensional, bi-dimensional, or
volumetric method. In a uni-dimensional method, the radiologist measures the
size of a nodule along the largest dimension on a single central slice. For a
bi-dimensional method, the radiologist marks the largest dimension on a sin-
gle central slice and then indicate the largest perpendicular measurement along
that dimension. Finally, in a volumetric method, the radiologist must outline
the nodule on every slice on which it appears and assesses the total volume in-
cluded by these boundaries. This method is the most time consuming for the
radiologist of the three methods. Examples of these three methods are illus-
trated in Figure 1.5. Although the three methods are measuring different quan-
tities, they are all usually converted into a volume measurement to produce a
volumetric doubling time or growth index.
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(a) (b)
(c)
Figure 1.5: Illustrative examples of a) uni-dimensional, b) bi-dimensional, and c)
volumetric measurement methods on the same nodule. A single slice is shown
for a) and b), while the all slices are shown for the volumetric measurement. a)
and b) are shown with a larger magnification factor than c).
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1.3.2 Automated pulmonary nodule measurement
To assist radiologists, automated methods of pulmonary nodule size measure-
ment have been developed that are capable of measuring the volume of a nodule
with minimal input from the radiologist. There are several different approaches
that have been applied to this area, but the most common approach is to ap-
ply image filtering to segment the nodule from the surrounding high-intensity
structures and low-intensity lung parenchyma. In this approach, a threshold is
applied to the image to separate soft tissue from lung parenchyma followed by
region growing or connected component analysis to eliminate structures not at-
tached to the nodule. Finally, filtering is applied to remove noise and attached
structures, such as vessels or the chest wall [22, 23]. Reeves et al. (2006) reported
low volume measurement variability, 11.5%, on 50 stable nodules [23]. Some
methods have explored ways to mitigate partial voxel effects. Ko et al. (2003)
modeled the expected proportions of voxels belonging to the nodule and lung
parenchyma, based on the size of the region and average intensity, to estimate
the nodule volume [24]. Their results on phantom nodules showed reduced er-
ror compared to a fixed threshold method, with a mean absolute error of 1.6
mm3 for the partial voxel method compared to 7.0 mm3 for the fixed threshold
method, for phantoms ranging in size from 7.5 mm3 to 60.7 mm3. Kuhnigk et al.
(2006) applied a refinement step to a nodule segmentation method to account
for the partial voxel effect by weighting the voxels in a fixed-width region at
the boundary of the nodule by the voxel intensity [25]. This method with par-
tial voxel effect compensation was found to have better volume reproducibility
than a plain segmentation method on an in vivo dataset of 96 nodules.
In addition to image filtering-based segmentation approaches, some algo-
rithms make use of more complex techniques such as active contours. A method
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proposed by Opfer and Wiemker (2007) applied an active contour-based ap-
proach utilizing a radial basis function energy minimization to the task of nod-
ule segmentation [26]. For 26 nodules greater than 300 mm3, the automated
method had a 95% limit of agreement of 59.8% compared to 70.2% for a radiolo-
gist. Another method by Wank, Engelmann, and Li (2007) used spiral scanning
to generate a 2D image from the 3D image data followed by a method to de-
termine the optimal outline of the nodule [27]. For 23 nodules from the LIDC
database, the method achieved a segmentation overlap value of 66%.
There have also been previous attempts at measuring nodule volume and
growth without explicitly segmenting the nodule. The work by Okada et al.
(2005) [28] relied on the size of a Gaussian kernel determined using a multi-
scale approach. The method by Kawata et al. (2005) computes nodule growth
rates from the CT density histogram [29].
1.4 Evaluating pulmonary nodule growth measurement systems
When evaluating pulmonary nodules, whether to determine malignancy or asses
the response to treatment, radiologists often rely on the nodule growth rate com-
puted from CT scans. As described in the previous section, there are many
methods of measuring pulmonary nodules and their growth; the critical con-
cern is the accuracy and precision of the growth rate computed by a method.
In this context, the accuracy of a method is a measure of how close it is to
the “true” growth of a nodule, while precision is a measure of the variation
between measurements. If the distribution of errors is normally distributed,
then the mean error would be a measure of the accuracy, while the standard
deviation would be a measure of the variation or precision. An ideal method
would have a mean error of 0 with no variation.
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Although we are most interested in the accuracy and precision of a nodule’s
growth rate, most measurement methods compute growth by taking separate
volume measurements on at least two scans. Given that we have accurate and
precise methods of measuring time, any error or variation in the growth rate
measurement would come from the volume measurements, and so, character-
izing the accuracy and precision of the volume measurements is also important.
To actually determine the accuracy and precision of a method, the true growth
rate of a nodule is required, but this is impossible to directly measure in vivo.
Although comparing a method with the growth rate measured by a radiolo-
gist seems to be a natural evaluation metric, many studies, which are discussed
in Section 1.4.1, have shown that radiologists’ measurements are not very reli-
able. Another approach is to use phantoms where the true growth is known;
however, these phantom nodules are often not as complex as real nodules and
thus do not yield generalizable results. Yet another approach measures not the
growth rate of a growing nodule, but the growth of a nodule that should not
have any growth—either a stable nodule or a nodule in which repeat scans were
taken during the same session. Since the true growth is known (0%), any devi-
ations would be due to measurement error by the method, and it is hypothe-
sized that methods with lower variations from 0% will result in better accuracy
for growth rate measurement. Since the true growth of repeat scans is actually
zero, they are more suited for measuring variability than stable nodules, which
might in fact be growing slowly.
1.4.1 Variability of manual measurements and metrics
While growth rate is primary measurement of interest, there have been few
studies that have directly determined the accuracy of the growth rate measured
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by radiologists. Instead, most studies have assessed the variation of the size
measurements made by radiologists. These studies generally show that radiol-
ogists’ measurements show high variability and a lack of reproducibility.
There are several methods of manually measuring the size of a nodule, and
a study by Jennings et al. (2004) [30] concluded that growth assessment be-
tween three different types of manual measurement—diameter, cross-sectional
area, and volume computed from summing the cross-sectional areas of all the
slices—often disagreed. Other studies in the area have focused on the varia-
tion of nodule size measurements, rather than growth. The variation is often
characterized by interobserver agreement—how closely the measurements of
multiple radiologists agree—and intraobserver agreement, which compares the
measurements of the same radiologist made at multiple times or on different
scans.
One study by Wormanns et al. (2000) [31] found good interobserver agree-
ment between radiologists, based on uni-dimensional (diameter) measurements
taken on CT scans. The scans were acquired using a high dose protocol (250
mA, 120 kV) and thick slice reconstruction, 5 mm and 3 mm. Other studies
on size measurement have found limited agreement amongst radiologists. Bo-
got et al. (2005) compared bi-dimensional measurements (long-axis and short
axis dimensions) made by four radiologists using film and two computer work-
stations [32]. On their dataset of 55 nodules, imaged using 5 mm thick scans,
there was considerable variation both among the radiologists and within the
radiologists – on the order of 60% in the best case. Other studies by Revel et
al. (2004) [33] and Erasmus et al. (2003) [34] also found large inter- and intra-
observer variation using two-dimensional and uni-dimensional measurements.
While the above studies used only uni- and bi-dimensional measurements,
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there is also large variations in manual volumetric measurements, where radi-
ologists draw a boundary around the nodule on every slice where the nodule
appears. Biancardi et al. (2009) measured the variation for both manual volu-
metric and uni-dimensional measurements and found wide limits of agreement
for the manual volumetric measurements (-23.4%, 31.8%) with even higher vari-
ation for the uni-dimensional measurements (-43.8%, 80.2%) [35]. An analysis
of manual volumetric markings in the Lung Image Database Consortium study
by Ross et al. (2007) [36] also found disagreement between radiologists.
Not only have studies found disagreement between radiologists, but Bian-
cardi et al. (2007) [37] measured substantial variation in the reported nodule
size depending on which metric, uni-dimensional, bi-dimensional, or volumet-
ric, was used for nodule size measurement.
All of these studies support the conclusion that manual size measurement of
pulmonary nodules is inadequate for ground truth.
1.4.2 Measurement accuracy using phantom nodules
Since manually measured nodule sizes have large variations and are not suit-
able for ground truth, an alternative is to use phantoms of a known size. Phan-
toms are objects with a similar radiodensity to pulmonary nodules placed inside
another object that simulates the lung parenchyma. While phantoms may not
capture all the nuances of in vivo nodules, they have one important advantage—
phantoms have a known volume, and thus, the measurement accuracy can be
determined. The FDA has been involved in the development of a database of
phantom nodule scans [38], but most of the work in the area of nodule measure-
ment variability has been performed on in vivo nodules, which are described in
the following two sections. Phantoms are often used to help establish the er-
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Table 1.1: Summary of studies on nodule volume variability on stable nodule
datasets with semi-automated methods
Author Year # nodules Dose Software Variation
Kostis [20] 2004 94 H Research -29.8%, 33.4% *
Reeves [23] 2006 50 H Research -18.3%, 18.3% †
Marchianò [42] 2009 233 L Siemens -27%, 27% †
* 95% limits computed from provided data
† Results did not specify the mean percentage volume change
Dose: H indicates high dose (200 mA or greater), L indicates low dose (30 mA)
ror of new pulmonary nodule measurement algorithms [39, 24], but are usually
used in conjunction with experiments on in vivo nodules. Phantoms were also
used in some of the studies described in Section 1.5.2 to determine the effect of
various scanner parameters [40, 41].
1.4.3 Measurement variability using stable nodules
Stable nodules may be used to estimate the measurement variability, in addition
to using phantom nodules or nodules observed in the course of normal clinical
treatment. A truly stable nodule would have no change, and hence any mea-
sured change in size would be due to the measurement method or other factors
unrelated to the growth of the nodule. However, actual in vivo stable nodules
may not actually have no change, and thus the measured variations may not be
reliable indicators of method variability.
Three studies have estimated the measurement variability of semi-automated
nodule measurement algorithms on stable nodules with the results provided in
Table 1.1. The measurement variabilities listed in the table are the 95% limits of
agreement, computed according to the Bland-Altman method [43] where possi-
ble; otherwise the standard deviations were used to compute a 95% confidence
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interval (indicated in the table by †). All three studies used thin-slice scans (1.25
mm or less), although the method by Reeves et al. (2006) [23] , which had the
lowest variation, was evaluated on targeted scans (in-plane resolution 0.1875
mm, slice thickness 1.0 mm) which have a higher resolution than whole-lung
scans (in-plane resolution of 0.6–0.8 mm). The studies by Kostis et al. (2004) [20]
and Marchianò et al. (2009) [42] had similar levels of variation, on the order of
±30%, although Kostis et al. used standard-dose CT scans, which have less
noise than low-dose CT scans.
While these studies were able to quantify the measurement variation of semi-
automated methods using stable nodules, a limitation of these studies is their
assumption that stable nodules do not change in size. This means that the actual
variation of the method can not be measured independently of the actual varia-
tion in the nodule size. To address this problem, some more recent studies have
explored the use of zero-change scans that employ two scans acquired with a
very short interval of a few minutes.
1.4.4 Measurement variability using zero-change datasets
In order to isolate the variation in measurement contributed by the system, that
is, the scanner and measuring algorithm, from the variation caused by a change
in the nodule, scans need to be acquired where the nodule will not change. If
scans can be made of a nodule in a short period of time, on the order of minutes,
then the actual change of the nodule will be zero. These types of scans are re-
ferred to as “coffee-break” or “zero-change” scans—patients are usually asked
to leave and return to the CT scanner for the second scan, with enough time for
a coffee break. While these scans provide insight into the variability of a mea-
surement method, they have two disadvantages: one, the repeat scans expose
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Table 1.2: Summary of studies on nodule volume variability on zero-change
datasets with semi-automated methods
Author Year # nodules SR (mm) Software Variation
Wormanns [44] 2004 151 2.2 – 20.5 Siemens -20.4%, 21.9%
Goodman [45] 2006 43 4 – 19 GE AW -25.6%, 25.6% *
Gietema [46] 2007 218 3.2 – 9.7 Siemens -21.2%, 23.8%
Zhao [47] 2009 32 11 – 93 Research -12.1%, 13.4%
Rampinelli [48] 2009 83 5 – 10 GE ALA -38%, 60% †
(SR = Size range (diameter), AW = Advanced Workstation, ALA = Advanced Lung Analysis)
* The mean was not reported, only the width of the limits.
† Study reported results on standard-dose and low-dose scans, this represents the results on the low-dose scans.
the patient to additional, typically unnecessary radiation, and two, given that
the true change is known to be zero, methods can be designed to excel at this
task. Furthermore, this method does not capture the patient changes or scan-
ner changes that occur over the much longer time interval that corresponds to
clinical practice.
There are five main studies that have used zero-change scans to estimate
the measurement variability of semi-automated methods [44, 45, 46, 47, 48],
which are summarized in Table 1.2. Again, the variability is reported as the
Bland-Altman 95% limits of agreement. Of the five studies, the two studies by
Goodman et al. and Zhao et al. used standard dose scans[45, 47] while the
remainder were done on low dose scans (20 – 40 mAs). The semi-automated re-
search method developed by Zhao et al. had the lowest variation of the group,
which may be due to the much larger nodules imaged on standard dose scans
analyzed in their study. The remaining studies used nodule measurement al-
gorithms available in commercial CT workstations, which had variation on the
order of 25%, which is slightly better than the studies using stable nodules, ex-
cept for the study by Rampinelli et al. It is not clear why their study had much
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higher variation than the other studies—the authors proposed inaccurate seg-
mentation, changes in respiratory level, and imaging at different points in the
cardiac cycle as factors contributing to the variation, but these factors likely af-
fected other studies as well.
These studies on the measurement variability of semi-automated volumetric
methods using zero-change scans have shown variation on the order of 25%.
1.5 Sources of measurement variation
All nodule measurement methods have measurement variation, and in addi-
tion to the variation inherent to the method, the source of the variation may be
due to either the nodule or the scan. There have been several studies that have
attempted to determine what nodule characteristics and scan parameters affect
the measurement variation of automated methods.
1.5.1 Nodule characteristics
A nodule has several properties that might impact the precision of size measure-
ment, such as its size, shape, or location. The previously mentioned study by
Gietema et al. (2006) found that there was no influence of the nodule size on the
measured variation, but there was a weak effect of inspiration level [46]. Their
study also included what they termed “completely” segmented and “incom-
pletely” segmented nodules, with the incompletely segmented nodules having
a visually obvious exclusion of part of the nodule; the completely segmented
nodules had smaller variation than the incompletely segmented nodules. In the
study by Wang et al. (2008), 4225 nodules were measured by two radiologists
using semi-automated software [49]. The measurement variability was found to
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be affected by the nodule morphology, location, and size, however, in the study,
a large majority (86%) of nodules were measured to have the same volume by
both radiologists due to the exclusion of nodules where manual editing was
performed by any of the radiologists. Petrou et al. (2007) found a significant
influence of spiculated margins on the measurement variability [50]. Even the
presence of attached structures, such as blood vessels, may impact the volume
estimation [51].
1.5.2 Scan parameters
The slice thickness of the scan was found to have a significant effect on the
variation by Zhao et al. (2005) [52], Petrou et al. (2007) [50], and Ravenel et
al. (2008) [53], leading to most of them recommending that 1) a consistent slice
thickness be used and 2) the thinnest slices possible should be acquired. An
example of scans of a pulmonary nodule acquired at different slice thicknesses
is shown in Figure 1.6. The results of a study by Ko et al. showed that scans
with a higher current or high-frequency reconstruction algorithm had improved
precision [24].
The scanner technology was also shown to affect the measurement variabil-
ity. Das et al. (2007) used phantoms to quantify the absolute percentage error
of four different scanner types: a single-slice spiral CT, 4-slice multidetector CT
(MDCT), a 16-slice MDCT, and a 64-slice MDCT [40]. Standard and low dose
protocols using thick and thin collimation were performed as well. There were
statistically significant influence on the measurement variability from the scan-
ner type, protocol, location, and nodule size. Das et al. (2007) also performed a
study to determine whether the error from scanners of different manufacturers
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(a) 1.25 mm (b) 2.5 mm
Figure 1.6: Example of scans of the same nodule acquired with different slice
thickness
would be similar [41]. Using nodule phantoms, the 16-slice scanners from the
different manufacturers had different, but similar amounts of measurement er-
ror: the mean absolute percentage error was 8.4%, 14.3%, 9.7%, and 7.5% for the
Siemens, GE, Philips, and Toshiba scanners respectively.
1.6 Previous work on nodule segmentation by Reeves et al.
Most pulmonary nodule measurement algorithms measure the volume of a
nodule by segmenting the nodule from the lung parenchyma and other attached
structures and computing the volume of the segmented image. One such algo-
rithm was developed by Reeves et al. (2006) [23] and was used both as a refer-
ence algorithm and as a basis for many of the improved algorithms described
in the following chapters. The basic steps of the algorithm are:
1. Estimate the size and location of the nodule based on a seed point,
2. Perform resampling, applies a threshold, and
3. Filter the image to remove attached structures.
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Figure 1.7: Overview of nodule segmentation method
An overview of the method is shown in Figure 1.7.
The segmentation method is initialized with a manually specified seed point
within the nodule. To help reduce the variation in segmentation due to different
seed point positions in the same nodule, a new estimated nodule location is de-
termined from the seed point. Starting from the seed point, an iterative process
estimates the nodule size and location using spherical Gaussian and Laplacian
of Gaussian templates. An estimated location is determined by finding the loca-
tion that best matches a Laplacian of Gaussian template of a given radius. Next,
the location is fixed, and Gaussian templates of various sizes are tested to deter-
mine the best estimate of size for the location. This process is repeated until the
location and size estimates converge or a given number of iterations is reached.
The size and location estimate are used to extract a small region of interest
(ROI) from the CT scan. By selecting an ROI from the CT scan, the amount of
image data to be analyzed is considerably reduced. The ROI is centered at the
nodule location and has a size of twice the nodule size. The ROI is resampled
into isotropic space (where the three-dimensions of each voxel are the same) us-
ing tri-linear interpolation. Typically, CT scans have a resolution of 0.6 mm x 0.6
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mm x 1.25 mm, which is resampled to 0.25 mm isotropic resolution. Resampling
the ROI serves two purposes: it enables subvoxel precision for segmenting the
nodule, and it simplifies later processing of the image.
At this point, the algorithm has an estimate of the nodule location and size,
and a resampled, isotropic ROI. The nodule is separated from the lung parenchyma
by applying a threshold to the ROI; this is based on the fact that, within the lung,
there are two main tissue types—-lung parenchyma and soft tissue (nodules,
vessels, chest wall, blood). After applying a threshold to the ROI, the result is
a binary image, with voxels belonging to soft tissue assigned a value of 1 and
everything else assigned a value of 0. An example of the ROI before and after
thresholding is shown in Figure 1.8.
After thresholding the image, a series of filtering operations is performed
to remove noise and attached structures. A connected component analysis re-
moves structures with a high intensity not connected to the central component.
After this step, a single connected component remains – this usually consists of
the nodule and adjacent structures such as blood vessels or the chest wall. To
remove blood vessels, a series of morphological operations is performed. First,
a morphological opening operation is applied to the image, using a spherical
kernel set empirically to 0.75 times the estimated nodule radius. The opening
operation removes some of the fine surface features on the nodule, so to regain
these features, iterative morphological dilation is performed, starting from half
the initial kernel size and halving the size in each iteration. The result of this
algorithm for the nodule from Figure 1.8 is shown in Figure 1.9.
Finally, if the nodule is juxtapleural, a surface removing algorithm is per-
formed. The details of the method are further described by Jirapatnakul et al.
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(a) (b)
(c)
Figure 1.8: Example of axial slices of a nodule ROI a) before and b) after thresh-
olding. A 3D rendering of thresholded image is shown in c).
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(a) (b)
Figure 1.9: Result of morphological filtering to remove noise and attached struc-
tures shown as a) axial slices and b) a 3D rendering
(2011) [54], but in brief, the pleural surface is modeled using a three-dimensional
cubic function. Robust statistics are used to ensure that the points used in the
surface estimation actually belong to the pleural surface and not the nodule or
other attached structures. From these points, an estimation of the pleural sur-
face can be computed and used to separate the juxtapleural nodule from the
pleural surface.
At the end of this step, the algorithm returns a binary, isotropic image of
the nodule segmentation. To compute the volume of the nodule, the number of
(supersampled) voxels in the segmentation that have a value of one is summed
and multiplied by the voxel size.
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1.7 Overview of work on automated methods of pulmonary nod-
ule growth measurement
The work described in this dissertation is focused on advancing the field of auto-
mated pulmonary nodule growth measurement in three main areas: determin-
ing a quantitative evaluation method through the development of a common
dataset and evaluation metrics, improving pulmonary nodule growth measure-
ment accuracy and variability, and adapting these automated methods to pre-
clinical studies with mouse models.
The evaluation of pulmonary nodule growth measurement methods is diffi-
cult without a common dataset or evaluation criteria. In Chapter 2, the VOLu-
metric Change Analysis of NOdules (VOLCANO) study is described. A dataset
of 49 nodules, including nodules with both zero-change and actual growth, and
a single phantom was prepared and made publicly available for different re-
search groups and manufacturers to analyze with their methods. The results of
18 different methods were evaluated for agreement using non-parametric sta-
tistical measures. This was the first study and dataset that concentrated specifi-
cally on pulmonary nodule growth measurement, and this study determined a
benchmark for the state of the art.
The second major topic addressed in this dissertation is the development of
two new methods for improving nodule growth rate measurement. The first
method, described in Chapter 3, reduced measurement variation by applying
compensation in the z-axis using moment analysis of a segmented nodule im-
age. This addresses the uncertainty from the anisotropic CT scan acquisition
method for voxels in the xy plane compared with the z plane. This method
shows a promising reduction in measurement variability compared to methods
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without compensation. The second method, discussed in Chapter 4, addresses
nodules that are difficult to segment—nodules with complex shapes and attach-
ments or non-homogenous density. Instead of explicitly segmenting the nodule,
this method computes the change in density over a region of interest as a sur-
rogate measure of growth. The growth rates computed by this density-based
method were better able to distinguish malignant from benign nodules than the
growth rates of a segmentation-based algorithm.
While these methods and many others have been developed for measuring
nodule growth in human patients, there are few automated methods for mea-
suring pulmonary nodule growth in mouse models. Many pre-clinical studies
use mouse models to aid in the development of new treatments or better under-
stand the underlying physiology of cancer. In Chapter 5, a automated segmen-
tation algorithm is modified for measuring pulmonary nodules of small animals
imaged with micro-CT. To evaluate the algorithm, instead of using manual mea-
surements as ground truth, the growth rate measured by the algorithm was
compared to the exponential growth model. On a dataset of six nodules iden-
tified on four mice, the algorithm was able to successfully segment the nodules
and estimate growth rates that were good fits to the exponential model.
A final summary of all the research accomplishments is given in Chapter 6.
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CHAPTER 2
EVALUATION OF AUTOMATED GROWTH MEASUREMENT
METHODS: VOLCANO
A primary indicator of malignancy for early stage lung caner is the growth
rate of pulmonary nodules. Accurately measuring the growth rate of pulmonary
nodules is especially important in cases of malignant, slowly growing nodules—
by reducing the uncertainty in the growth measurement, diagnoses may be
made earlier, improving patient outcomes. As discussed in Chapter 1, there
is considerable uncertainty in measurements by radiologists—given the same
nodule, the radiologist will provide a slightly different measurement each time.
In contrast, an automated method should consistently provide the same mea-
surement. Many different automated methods have been developed, but there
have been no studies which have compared automated methods to each other
on the exact same dataset with identical evaluation methodologies.
The VOLumetric Change Analysis of NOdules (VOLCANO) study [55] was
developed to compare different automated methods on the same dataset. The
methods were compared for consistency in growth measurement. In develop-
ing the study, cases were selected to address the issues of varying slice thick-
ness between scans, the use of zero-change nodules for evaluation, and the
nodule characteristics that may affect measurement uncertainty. The evaluation
methods for this study were designed to not rely on any human measurements,
based on the understanding that human measurements are not reliable enough
to serve as ground truth, and to analyze the growth measurement directly, in-
stead of size measurements.
In this study, 18 algorithms from 13 research groups were evaluated on a
database of 49 real nodules and one synthetic nodule. This study both bench-
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marked the current state of the art in nodule growth measurement and provided
the framework by which new algorithms may be evaluated.
2.1 VOLCANO study design
In the evaluation of automated nodule growth measurement algorithms, we are
interested in the accuracy of their growth measurements in a wide variety of
pulmonary nodules. This is made difficult by the lack of available ground truth,
as was described in Section 1.4. We addressed this lack of ground truth by us-
ing two surrogate approaches: measuring the variability of the algorithms using
nodules that have zero-change and synthetic nodules with a known change in
size. Zero-change nodules allow for the characterization of bias, but it is trivial
for an algorithm to produce a result of 0 and algorithm performance may vary
from the zero-change case. Synthetic nodules provide a means to verify the ac-
curacy of the algorithms, since the size change and density are known, but they
fail to fully capture the complexity of a nodule in vivo – real nodules have attach-
ments, density inhomogeneity, and varying intensity along their margins. Real
nodules with growth were also included in the database; these nodules have
pairs of scans at a sufficiently large time interval to ensure that actual growth
occurred.
Taking these considerations into account, the study involved measuring the
change in nodule size for 50 scan pairs divided into the categories above. To as-
sess how algorithms are affected by a change in slice thickness, the zero-change
nodules were divided into two groups—nodules imaged on scans of the same
slice thickness and nodules imaged on scans of different slice thickness. Thus,
the data may be divided into four subgroups:
1. (14) zero-change in which the scans were taken minutes apart and there-
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fore there is no real change in the nodule size.
2. (13) zero-change cases as in A above except one scan had a slice thickness
of 1.25 mm and the second scan had a larger slice thickness (2.5 or 5.0 mm)
3. (19) nodules with a significant time interval between scans and therefore
some real change and (3) nodules with a large change in size of greater
than 150%, one of which was known to be malignant. Of these nodules,
19 were considered to be stable or benign by biopsy and 3 were diagnosed
as malignant.
4. (1) synthetic phantom nodule with a known size recorded multiple times
with different slice thicknesses
Four additional scan pairs were made available to research groups for training.
No information was provided regarding the subgroup of any of the nodules,
but participating research groups in the study were aware of the existence of
the four subgroups. The participants reported the fractional change in nodule
size for each of the 50 scan pairs. Thirteen different participants submitted their
measurement change results from on a total of 18 different methods. In 12 of
these methods, the actual volumes recorded for each nodule were also reported.
In general, the main interest is to learn the smallest size change which can be
reliably detected and the precision of that size change measurement. A number
of studies on repeat scans have been reported in the literature [44, 45, 46, 47, 48],
which are described in Section 1.4.4, and in these studies, the limits of agreement
for repeat scans of the same nodule are on the order of 20-25% by volume. For
these reasons, most of the cases in data set C were selected to have a size change
within the range of ±50%. For completeness, three cases with a very large size
change (150% or more) were included to characterize the measurement methods
for such situations.
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Figure 2.1: Size distribution of nodules in the evaluation dataset
2.1.1 Image data and preparation
The image data used in the study were acquired for the Public Lung Database
to address drug response [56] and were provided by the Weill Cornell Medical
College with the exception of one case of a synthetic “phantom” nodule pro-
vided by the FDA [38]. Cases were selected that contained at least one nodule
of solid consistency which was present in at least two scans with a whole-lung
field of view; only nodules visible on at least three slices on both scans were
included. The size distribution for the real nodules used in this study is shown
in Figure 2.1.
The scan pairs in group A had the same slice thickness for both scans; in
13 cases, both scans had a slice thickness of 1.25 mm while one case had scans
with a slice thickness of 2.5 mm. For group B, 11 cases had scans with 1.25 mm
and 2.5 mm slice thickness, while two cases had scans of 1.25 and 5.0 mm slice
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Table 2.1: Summary of scan parameters for nodules in the dataset
Group Current (mA) Scanner Models
A 40-250 GE LightSpeed {Ultra, QX/i, Pro 16}
B 20-80 GE LightSpeed {Ultra, QX/i}
C 40-80 GE LightSpeed {Ultra, Pro 16, VCT}
D 40 Philips MX8000 IDT 16
thickness. All the scans in group C had a slice thickness of 1.25 mm. Scans
in these three groups were acquired without overlap. All scans were acquired
using a voltage of 120 kVp. The current and scanner model for each of the
groups are listed in Table 2.1.
For group C, the status of each nodule was determined by a radiologist; sta-
ble nodules were either biopsied (3) or did not have any clinical change in 2
years (16), while the three malignant nodules were biopsied.
Group D was comprised of the synthetic phantom nodule, a 10 mm (523.60
mm3) sphere with two different slice thickness reconstructions, 1.5 mm and 3.0
mm with 50% overlap. All scans have a whole-lung field of view. The phantom
was placed in a chest phantom with simulated vascular structures [38].
In five zero-change cases, the patient position changed between prone and
supine in the scans; one case was in group A while four cases were in group B.
Prior to making the images available for the study, all identifying patient
information was removed. The original dates of the scans were replaced with
dates corresponding to a time interval of 100 days between scans, with the order
of the scans was randomized. The scans were then clipped in the axial direction,
with the five slices below and above the region containing the nodule included
if possible. This was done because some of the scans did not cover the whole-
lung in the axial dimension and to reduce the amount of data to be downloaded
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for this study. Along with the scans, participants were provided with a spread-
sheet identifying the approximate center of the nodule established by a human
observer.
2.2 VOLCANO evaluation metrics
We seek to quantify the bias and variation when evaluating a nodule growth
measurement algorithm. In general, the bias measures the deviation from the
true value, while the variation measures the spread of observations. The dis-
tinction between bias and variation is illustrated in Figure 2.2; the true value is
indicated by the center of the “bulls-eye”. In the context of nodule growth mea-
surement, the bias of an algorithm is a measure of its deviation from the true
growth of the nodule. Variation is the range or “dispersion” of growth mea-
surements for nodules with identical growth. For example, given multiple scan
pairs of a set of synthetic nodules with a known, fixed difference in size, bias
would characterize the deviation of an algorithm from the true change in size,
while variation characterizes the range of measurements. In the ideal case, both
bias and variation would be zero.
To quantify the bias and variation of nodule growth measurement algo-
rithms, the change in size is required. While the time span of the size change is
also required to measure growth, we assume that any bias and variation will be
due to the size measurement and not the time measurement. In the VOLCANO
study, participants were requested to provide a size change metric for each nod-
ule, from which metrics were derived to quantify the bias and variation.
For methods that measure the volume of the nodule on each scan, the size
37
(a) Low bias and low variation (b) Low bias with high variation
(c) High bias with low variation (d) High bias and high variation
Figure 2.2: Illustration of the distinction between bias and variation and the four
possible combinations of low and high bias and variation
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change metric is the relative volume change (RVC):
RVC =
V2
V1
− 1 (2.1)
where V2 and V1 are the volumes measured for the nodule on scan 2 and scan 1
respectively.
The metric that was requested for results (relative change with respect to
time 1) is asymmetric with respect to the order of presentation: no change in
size has a value of 0, a 10 times increase in size results in a value of 9 while
a 10 times decrease in size results in a value of -0.9. The negative size change
is bounded by -1 while the positive size change is unbounded. In the dataset
provided to the participants, the order of the scan pairs was randomized. It is
possible to reverse the order, that is computing the relative size change from
scan two to scan one by the following transformation:
RVC’ =
1
RVC + 1
− 1 = V1
V2
− 1 (2.2)
where RVC represents the reported relative size change reported by the partic-
ipants. However, if any of the methods has an order bias, adjusting the results
to match the correct time sequence would mask such an effect. The one data
set where ordering is important is data set B which had scans of different slice
thicknesses; we transformed the results so that the thin slice scan was always the
first in the pair to determine the effect caused by a change in slice interval. For
the other datasets, transforming the RVC to restore the correct temporal order
of the scans was not performed.
This study provides an opportunity to analyze several aspects of automated
nodule change measurement performance. We can draw conclusions about the
performance of the algorithms on the different nodule groups (A-D), compare
the algorithms to each other, and attempt to determine what nodule character-
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istics may affect the performance of the algorithms. The evaluation metrics are
described in the following sections.
2.2.1 Statistical descriptors of general algorithm performance
for each nodule group
One facet of automated nodule change measurement performance we seek to
study is how the algorithms, in general, behave on datasets with different char-
acteristics. In the case of zero-change nodules, where the scans are taken min-
utes apart from each other, the true growth is zero. Based on this, we can mea-
sure both the variation and bias of the methods on the zero-change datasets,
group A and B. For the nodules in group C, the true size change is unknown, so
it is difficult to interpret the bias, but it is provided for consistency. Finally, for
group D, the phantom nodule, the true size and volume change is known.
Given the relatively small number of nodules in each category, non-parametric
statistical descriptors were used in this study, since the assumption of normal-
ity may not be satisfied. To quantify the variation and bias of each group, the
median of the median of absolute deviation (MMAD) and median of the abso-
lute median (MAM) were computed for each group of nodules. The median of
the absolute deviation (MAD) is computed by taking the median size change
metric for each nodule (across all methods), and, for each method, computing
the absolute deviation from the median. This results in a MAD value for each
nodule. The median of the MAD values of the nodules in a group is the MMAD
for the group. Given the set Si of size change measurements for m methods for
a nodule i ,
Si = {si,1, si,2, . . . , si,m}
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the median size change (MS) is
MSi = median(Si)
the absolute deviation for each method a is
|Da| = |si,a −MSi|
and the median of the absolute deviation is
MADi = median(|D1| , |D2| , . . . , |Dm|)
Let there be n nodules in each group, then the MMAD for a particular group is
MMAD = median(MAD1, MAD2, . . . , MADn)
A higher MMAD value indicates a group of nodules that has higher variation.
To quantify the bias from zero, the MAM is computed by taking the median
of the absolute median size change metric for each nodule:
MAM = median(|MSC1| , |MSC2| , . . . , |MSCn|)
The MAM provides an estimate of the bias for a particular group. For zero-
change nodules, the methods should report a size change metric of 0, which
would result in a MAM of 0 as well. Nodules that have a bias will have positive
MAM values. Note that these metrics are computed for each nodule and group;
these are not descriptors of the performance of a specific algorithm.
2.2.2 Graphical comparison
The MAM and MMAD provide statistical descriptors of the different groups
of nodules. To gain a better understanding of how the methods behaved on
individual nodules, box-and-whisker plots were made for each nodule in all
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the datasets. These plots provide a graphical representation of the following
data:
• median (dark line in center of box)
• 25th and 75th percentiles (top and bottom of box)
• the highest and lowest values within 1.5 times the interquartile range (IQR)
(top and bottom whiskers)
• outliers that fall outside 1.5 times the IQR (circles)
The median for a nodule would indicate the most likely measurement of the
size change, and hence the expected bias. The size of the box is related to
the amount of variation between the methods, with larger variations produc-
ing larger boxes. The whiskers and outliers also serve as a measure of variation,
with whiskers that are farther out or a large number of outliers indicative of
more variation. These plots can be used to analyze both the behavior of the
algorithms on specific nodules (by comparing nodules to each other) and the
performance of algorithms relative to each other.
2.2.3 Statistical comparison of different nodule groups
The statistical agreement between methods was established for the size change
measurements using the Friedman test. The Friedman test is a non-parametric
test that, in this study, assess whether or not the size change measurements
from the different methods are statistically different across an entire group of
nodules. To compare the behavior of groups, the Wilcox rank-sum test was ap-
plied to the MAD values computed for each nodule. This test assesses whether
the biases are statistically different between the groups.
42
2.2.4 Comparison of methods
In addition to the analyses described above, which primarily seek to measure
the performance of automated algorithms as a group, additional analysis can be
performed to attempt to distinguish methods from each other. With the avail-
able data and lack of ground truth, the methods were compared to each other
based on the number of times their measurements were outliers compared to
the entire group. However, this is not a measure of whether the algorithm is
providing the correct measurement; it serves only to distinguish methods from
each other.
2.2.5 The impact of nodule characteristics
We hypothesize that nodule characteristics can be identified that affect the mea-
surement performance of an automated nodule growth measurement algorithm.
A previous study by Wang et al. (2008) [49] found that the variation in size mea-
surement of nodules was affected by nodule location, morphology, and size.
Since this study includes many different algorithms, we can assess whether
there are nodule characteristics that universally affect automated algorithms.
To address this, the presence of various nodule characteristics was determined
by visual inspection of the nodules.
The examined characteristics can be divided into two categories: 1) charac-
teristics that are attributable to the scanner and 2) nodule morphology. There
are four characteristics affected by the scanner: slice difference (SD), which for
the nodules in group B was the difference in the slice thickness for the nodules
in group B, or the difference in the number of slices on which the nodule ap-
peared for group A; whether the X-ray tube current was altered between scans
(CC); the presence of visible noise (N); and whether the position of the patient
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(a) (b)
Figure 2.3: Examples of a nodule a) with visible noise in the scan and a blood
vessel attachment and b) without noise or attachments.
was altered between scans (PC). The presence of visible noise was based on vi-
sual observation and judgment by the author; a comparison between a nodule
with noise and without noise is shown in Figure 2.3.
The three nodule morphology characteristics examined were the margin sharp-
ness (M), the presence of attachments (A), and the presence of spiculations (S).
The margin was either ill-defined (I) or well-defined (W), assessed by visual
observation of the author. Nodules with well-defined margins have a sharp
demarcation between the nodule and lung parenchyma, while nodules with ill-
defined margins have a larger zone of transition between the nodule and lung
parenchyma that may increase the uncertainty in growth measurement. A com-
parison of the two nodule types is shown in Figure 2.4. The nodules were ob-
served for attachments to either blood vessels or the chest wall, an example of
which is shown in Figure 2.3a, as well as spiculations, which are irregular points
or spikes on the nodule surface, shown in Figure 2.5.
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(a) (b)
Figure 2.4: Examples of a nodule with a) well-defined margins and b) ill-defined
margins. The margin is the size of the transition region from the nodule to the
lung parenchyma, and nodules with ill-defined margins will appear to have a
more blurred boundary.
(a) (b)
Figure 2.5: Examples of a nodule a) with spiculations and b) without spicula-
tions.
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For each nodule, the bias and variation were computed across methods. The
bias for a nodule i was computed as the median of the size change measure-
ments provided by all the methods for each nodule, MSi. The variation was
computed as the median of the absolute deviation, MADi. For the nodules in
group C with real growth, the bias was not included because the true change in
size of the nodule was unknown. The nodules were ranked according to their
bias and variation within their groups. The Wilcoxon rank sum test was used
to assess the statistical significance of each characteristic on both the bias and
variation.
2.3 Automated methods included in the study
Thirteen research groups participated in the VOLCANO challenge. Several
groups submitted multiple size change measurement methods for a total of 18
submitted methods. Although not required, 12 groups provided volume mea-
surements for each nodule. The research groups and their methods are summa-
rized in Table 2.2; methods provided by the same group have the same prefix.
The category of methods are described in additional detail below.
There were a wide variety of methods in the VOLCANO challenge. To make
comparison between the methods easier, we ranked the methods based on the
amount of operator interaction required and the types of algorithms employed
by the method.
The levels of operator interaction were divided broadly into three groups:
completely automated after specification of a seed point, manual parameter
control, and modification of the resulting boundary or indicating additional
control points. These categories were further subdivided according to the frac-
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Table 2.2: Summary of participating methods (PVC = partial voxel correction)
Method Automation Category
1 Tokushima 3 Image filtering
2 ISI-Sphere 4 Sphere fitting
3 ISI-Seg 4 Image filtering
4 ISI-Reg 4 Elastic registration
5 NYU-HYB 7 Image filtering with PVC
6 NYU-HYBA 7 Image filtering with PVC
7 UCLA 6 Image filtering
8 VIA-GAD 1 Density change
9 VIA-GAS 4 Image filtering
10 Kitware 4 Fast marching and shape detection level set
11 Duke 1 Spiral scanning, dynamic programming
12 Gifu 1 Image filtering
13 Biomedsys 2 Image filtering
14 MeVIS 3 Image filtering with PVC
15 Siemens 3 Image filtering with PVC
16 Philips 1 Active contour
17 Definiens 5 Image filtering
18 VIA-ZCOMP 4 Image filtering with Z-compensation
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tion of cases which required manual intervention. Groups were asked to rank
the level of automation required by their algorithms using the following scale:
1. Totally automatic using seed points
2. Limited parameter adjustment (on less than 15% of the cases)
3. Moderate parameter adjustment (on less than 50% of the cases)
4. Extensive parameter adjustment ( more than 50% of the cases)
5. Limited image/boundary modification (on less than 15% of the cases)
6. Moderate image/boundary modification (on less than 50% of the cases)
7. Extensive image/boundary modification ( more than 50% of the cases)
The scale is roughly in order of operator effort required, with methods requiring
only a seed point using the least about of operator effort. The level of automa-
tion required for each method is detailed in Table 2.2.
In addition to the level of automation, the methods were also categorized ac-
cording to the approach that was utilized. While the details of the methods all
differ, we divided them into three main categories: image filtering, image filter-
ing with partial voxel correction, and other approaches. These will be described
in the following sections.
2.3.1 Image filtering approaches
Methods that used the image filtering approach for measuring nodule size change
segmented the nodule using image filtering operations, such as thresholding,
morphological filtering, and connected component analysis, and used the change
in the segmented volume as the nodule size change. This approach was used by
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seven methods (Tokushima, ISI-Seg, UCLA, VIA-GAS (Vision and Image Anal-
ysis Group, Cornell), Gifu, Biomedsys, Definiens) is based on image filtering
operations [22, 23]. Generally, methods using this approach extracted a vol-
ume of interest (VOI) around the seed point for each nodule. This VOI was re-
sampled and a threshold applied to identify voxels belonging to high-intensity
structures. Next, either region growing or connected component analysis was
applied to the volume of interest to eliminate non-nodule structures, followed
by the removal of attached structures such as vessels or the chest wall using
morphological filtering or other more advanced techniques. The volume for
each nodule was computed from the voxel size and number of voxels included
in the segmentation; the size change metric for these methods was based on the
volume change. Additional details of the algorithms are provided below.
2.3.1.1 University of Tokushima (Tokushima)
The Tokushima approach to nodule segmentation relied upon several image
filtering operations to identify the VOI and segment the nodule. The lung re-
gion is segmented based on thresholding and connected component analysis.
Unique to this algorithm is a step that corrects for the background bias in the
lung region, which is responsible for a gradually increasing density towards
the periphery of the lung region. After the VOI is identified and background
bias correction performed, the nodule is segmented by removing noise from the
image, applying a threshold to the image, and removing attachments by mor-
phological operations.
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2.3.1.2 Image Sciences Institute Segmentation (ISI-Seg)
The ISI segmentation algorithm is very similar to the method described in Sec-
tion 1.6, with the addition of a 2D lung segmentation prior to segmenting the
nodule [57]. The 2D lung segmentation was performed using thresholding, con-
nected component labeling, and morphological operations [58].
2.3.1.3 University of California, Los Angeles (UCLA)
The algorithm used by UCLA is a seeded-region growing technique. The user
provides a seed point and a line from the seed point to the lung parenchyma.
Voxel intensities along the line are sampled to form a histogram from which
a threshold is determined to separate the nodule from the background. Using
this threshold, a 3D seeded region growing is performed starting from the user-
specified seed point.
2.3.1.4 Cornell volumetric method (VIA-GAS)
The VIA-GAS method is based on thresholding followed by morphological fil-
tering and vessel removal. It is described in detail in Section 1.6.
2.3.1.5 Cornell z-compensation method (VIA-ZCOMP)
The VIA-ZCOMP method uses moment analysis to compensate for variation
in the z-dimension of the scan. This computes the moments on the segmented
image from the VIA-GAS method, and is described in further detail in Chapter
3.
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2.3.1.6 Gifu University (Gifu)
The method provided by Gifu University is a nodule segmentation method pri-
marily based upon the refinement of a thresholded region and described in fur-
ther detail by Hayashi, Zhou, and Fujita (2009) [59]. In the first stage of the algo-
rithm, the lung region is segmented using thresholding, connected component
analysis, and morphological filtering. The nodule is segmented by applying
rules to the distance transform image to isolate vessel-like structures, followed
by thresholding, connected component analysis, and morphological filtering.
2.3.1.7 Biomedical Systems (Biomedsys)
Biomedical Systems provided results from their LifeRxTMvolume tool. Using
the tool, a user creates initial boundaries around the VOI; these boundaries need
not be done on every slice. The user also provide seed points within the nodule,
and a segmentation is performed based on the histogram of the VOI.
2.3.1.8 Definiens
The Definiens method is a 3D region growing-based algorithm implemented in
the Cognition Network Language [60]. The lungs and other anatomical objects
are first segmented from the image. Given a seed point, a seed object is seg-
mented from the image based on similar image intensities and proximity. Based
on this seed object, the histogram is analyzed to determine the lower and upper
bounds for the intensity. The seed object is grown using the intensity informa-
tion and adaptive surface tension. Finally, morphological filtering is performed
to refine the segmentation. The algorithm was developed primarily for large
tumors and trained with cases with a variety of resolutions. Although only a
seed point needs to be specified, manual editing of the boundary is possible.
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2.3.2 Image filtering with partial voxel correction
Four methods (MeVIS, NYU-HYB, NYU-HYBA, Siemens) extended the image
filtering approach to better address partial voxels along the perimeter of the
nodule [24, 25]. These methods determined a region around the border of the
nodule where the voxels have intensity between that of solid tissue and the lung
parenchyma; based on histogram analysis, these voxels were weighted when
computing the nodule volume.
2.3.2.1 New York University (NYU-HYB and NYU-HYBA)
The two methods used by NYU both performed additional analyses on the vox-
els at the nodule-lung parenchyma interface [24]. First, the methods begin by
generating a small seed region at the center of the nodule. Voxels are selected
by applying a threshold determined from this small seed region. Morphological
erosion is performed on the region, followed by connected component analysis
and region growing. The growing operation is devised to over-segment the
nodule and include some of the surrounding structures, designated as region I.
Next, an adaptive threshold is determined by finding the midpoint of the inten-
sities of voxels on the edge of the region and voxels towards the center, resulting
in a region J.
In the NYU-HYB method, region J is eroded by 3 voxels, forming a new re-
gion H. The region between I and H, that is, I − H, is a hollow shell that should
contain voxels along the boundary between the nodule and lung parenchyma;
some of these voxels are likely to be partial voxels. A portion of the volume
of these voxels can be included in the nodule volume based on their intensity
relative to the intensities of the region.
The NYU-HYBA is a variant of the NYU-HYB method that uses fixed inten-
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sities thresholds instead of determining the values from the voxel intensities of
the region.
2.3.2.2 MeVIS
The method presented by MeVIS is described in detail by Kuhnigk et al. (2006)
[25]. Much like the NYU methods, additional steps are performed to achieve
better accuracy along the boundaries of the nodules; after segmentation, the
region along the boundary of the nodule is identified and voxels within this
region contribute partially to the volume of the nodule.
2.3.2.3 Siemens
Siemens provided results from an algorithm that is available as part of one of
their commercial products, Oncology, Syngo MMWP VE31 A. The algorithm is
initialized using either a seed point or by providing a line across the largest di-
ameter of the nodule. A VOI is extracted from the CT scan, and 3D region grow-
ing is performed starting from the seed point or line. Morphological operations
are used to separate the nodule from any attached structure. Finally, a check is
performed of the resulting segmentation to ensure that the location of the initial
conditions is sensible, relative to the segmentation. If not, the algorithm repeats
with slightly different thresholds.
2.3.3 Other approaches
The remaining six methods used different approaches. Most methods resam-
pled the CT scans into isotropic space.
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2.3.3.1 ISI-Sphere
ISI-Sphere estimated the best fitting spherical volume of interest at the seed
point of the nodule from a thresholded, resampled volume of interest [57]. The
volume of the nodule was estimated from the number of voxels above a thresh-
old.
2.3.3.2 ISI-Registration
The ISI-Registration method applied non-rigid registration to deform the first
scan to the second; this transformation was then applied to a segmentation ob-
tained for the first scan to obtain the volume of the nodule on the second scan
[57].
2.3.3.3 Kitware
Kitware required only a manually specified seed point and a bounding box.
Their method computed several features for each voxel, including lung wall,
vesselness, gradient, and intensity features which were aggregated and used
to guide a fast marching algorithm to generate an initial guess of the nodule
boundary. The initial boundary estimate was refined using a shape detection
level set. The volume was computed from the surface of the resulting level set.
2.3.3.4 Duke
Duke used a spiral-scanning technique to convert the 3D volume of interest
around the nodule to a 2D generalized polar coordinate system. Dynamic pro-
gramming techniques were used to obtain the nodule boundary on the 2D im-
age which was then transformed back into 3D space [27]. This boundary was
applied to the original 3D image to estimate the nodule volume.
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2.3.3.5 Philips
Philips used an active contour-based approach utilizing a radial basis function
energy minimization algorithm [26].
2.3.3.6 VIA-GAD
In contrast to the methods described thus far, VIA-GAD (Cornell) did not explic-
itly segment the nodule; instead, the change in nodule size was estimated from
the change in density of a Gaussian-weighted region around the nodule [61].
This method is described in detail in Chapter 4 as the density growth index
method using a Gaussian weight (DGIG).
2.4 Results
The results of the study can be divided into three broad categories: group re-
sults, individual method results, and nodule results. Group results indicate the
behavior of all the automated methods for each group of nodules, individual
method results showcase the performance of each method, while nodule results
provide information on the behavior of the methods for each nodule.
2.4.1 Group results
Box and whisker plots, plotted for the size change measurements for the differ-
ent groups, are shown in Figure 2.6 to 2.10a. Note that in these plots, the x-axis
represents a random identifier that differs from the case ID provided to the par-
ticipants. For group C, due to the large change in three nodules, two plots are
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Figure 2.6: Box plot for group A: zero-change, same slice-thickness. For each
nodule, the median of the relative volume change (RVC) is plotted as the dark
solid line within the box. The lower and upper bounds of the box represent
the 25th and 75th percentile of RVC, and the whiskers indicate the lowest and
highest RVC within 1.5 times the interquartile range. Any RVC measurements
that lie outside 1.5 times the interquartile range are indicated by circles.
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Figure 2.7: Box plot for group B: zero-change, different slice thickness. The
volume change was computed so that the first scan always had a slice thickness
of 1.25 mm, while the second was 2.5 mm except for cases 3 and 21 which was
5.0 mm.
Figure 2.8: Box plot for group C: actual small change (one outlier not shown)
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Figure 2.9: Box plot for group C: actual large change (the size change of the first
nodule was inverted for visibility)
shown for clarity (Figures 2.8 and 2.9).
Although the primary focus of this study was on size change measurement,
not volume measurement, participants were requested to provide volume mea-
surements if available. Of the 18 methods submitted, 12 methods provided vol-
ume measurements. For the phantom, the only case where the true volume was
known, a box plot is provided in Figure 2.10b for each scan. In the figure, the
second scan was reconstructed at twice the slice thickness of the first scan.
Bias and variation results in the form of the median of absolute medians
(MAM) and median of absolute deviation (MMAD) are provided in Table 2.3.
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(a) Size change varia-
tion
(b) Volume estimates for
12 of 18 methods that pro-
vided size estimates. The
horizontal line indicates
the true volume of the
phantom (523.60 mm3)
Figure 2.10: Box plot for group D: phantom nodule
Table 2.3: Summary of the median of absolute median (MAM) and median
of median of absolute deviation (MMAD) of the relative size change measure-
ments for each group, which measure the bias and variation respectively. Note
that the results of group D are on a single nodule.
Group A Group B Group C Group D
MAM 0.0554 0.0953 0.1719 0.0620
MMAD 0.0408 0.0842 0.0680 0.0490
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Table 2.4: Number of outliers produced by each method, according to group
Method Automation Type A B C Total
Biomedsys 2 IF 0 0 3 3
Definiens 5 IF 0 3 6 9
Duke 1 O 0 0 1 1
Gifu 1 IF 0 0 0 0
ISI-Reg 4 O 5 3 5 13
ISI-Seg 4 IF 2 0 0 2
ISI-Sph 4 O 2 4 5 11
Kitware 4 O 3 2 2 7
MeVIS 3 IFP 1 0 0 1
NYU-HYB 7 IFP 1 0 1 2
NYU-HYBA 7 IFP 0 0 0 0
Philips 1 O 0 0 1 1
Siemens 3 IFP 1 0 0 1
Tokushima 3 IF 2 0 1 3
UCLA 6 IF 0 0 1 1
VIA-GAD 1 O 2 2 8 12
VIA-GAS 4 IF 0 0 1 1
VIA-ZCOMP 4 IF 0 2 2 4
2.4.2 Individual results
The size change measurements were reviewed to determine how many outlier
measurements each method produced. An outlier was defined to be outside
1.5 times the interquartile range for the nodule. The results are shown in Ta-
ble 2.4. This test only serves to show, generally, which methods showed more
agreement with the other methods; it does not suggest that a method is closer
to “truth”.
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2.4.3 Nodule and scan characteristics
The bias and variation, provided by the median and median absolute deviation
(MAD), are given for each group in Tables 2.6, 2.8, and 2.10. The statistical
significance of each of the nodule and scan characteristics are provided for each
group in Tables 2.7, 2.9, and 2.11. The key for the column title abbreviations is
provided in Table 2.5. The meaning of slice difference (SD) differs in group A
and group B. In group A, SD indicates the difference in the number of slices on
which a nodule appears on each scan. For example, if on one scan, the nodule
appears on three slices, but appears on five slices on the second scan, SD would
be two. Since the nodules in group A are supposed to represent zero change, SD
should ideally be 0. In group B, since the slice thicknesses varied between the
two scans, SD indicates the slice thickness of the two scans. SD is not relevant
to the nodules in group C.
The volume of each nodule, as measured by the VIA-GAS algorithm, was
also included in the table of nodule properties for each group. Neither the bias
nor the variation was correlated with the nodule volume in group A (Spear-
man’s rank correlation for bias: ρ = 0.288, p = 0.318; and variation: ρ = −0.315,
p = 0.273) or in group B ((Spearman’s rank correlation for bias: ρ = −0.154,
p = 0.617; and variation: ρ = 0.011, p = 0.978). The variation in group C
was also not significantly correlated with the volume, with a Spearman’s rank
correlation ρ = −0.367 and p = 0.123.
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Table 2.5: Key for column headings; see Section 2.2.5 for more details.
Abbreviation Meaning
Vol.1 Volume on first scan
SD Slice difference
CC Current change
A Presence of attachments
N Presence of visible noise
M Margin: I=ill-defined, W=well-defined, M=Mixed
S Presence of spiculations
PC Position change of patient
Table 2.6: Bias and variation for group A and associated nodule properties
ID Bias (rank) Var. (rank) Vol.1 (mm3) SD CC A N M S PC
28 -28.9% (1) 3.5% (8) 739.4 1 N N N I N N
15 -28.0% (2) 5.6% (3) 265.9 1 Y N Y W N N
39 -26.6% (3) 6.4% (2) 741.3 3 N Y N I Y N
24 -19.5% (4) 7.8% (1) 620.1 0 Y Y N W N N
49 -8.6% (5) 2.4% (10) 2859.3 0 N Y N W N N
11 7.8% (6) 1.8% (14) 1626.7 0 N Y N W N N
33 6.6% (7) 4.9% (5) 373.4 0 N Y Y W N N
23 -4.8% (8) 2.9% (9) 1963.1 1 N Y N W N N
20 -2.1% (9) 1.8% (13) 943.7 0 N Y N W N N
13 -1.8% (10) 4.5% (6) 10146.1 0 N Y N I Y N
14 -1.7% (11) 5.2% (4) 6966.1 0 N Y N I Y Y
18 -1.2% (12) 4.2% (7) 2083.5 0 N Y Y W N N
21 -0.7% (13) 2.1% (12) 1263.1 0 N N N W N N
36 0.0% (14) 2.2% (11) 779.1 0 N N N W N N
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Table 2.7: Statistical significance of nodule properties for group A (Wilcoxon
rank sum test)
Bias Variation
SD 0.008 0.288
CC 0.132 0.055
A 0.635 0.620
N 0.769 0.275
M 0.240 0.179
S 0.770 0.119
PC 0.857 0.456
Table 2.8: Bias and variation for group B and associated nodule properties
ID Bias (rank) Var. (rank) Vol.1 (mm3) SD CC A N M S PC
17 -62.1% (1) 5.7% (9) 1629.9 1.25,2.5 N Y N I Y N
12 -47.5% (2) 5.6% (10) 4027.2 1.25,2.5 Y Y Y I N N
3 -25.5% (3) 5.8% (8) 2119.8 1.25,2.5 Y Y Y W N N
26 -19.8% (4) 4.2% (13) 1114.0 1.25,2.5 Y Y N W N N
22 12.1% (5) 10.6% (3) 334.0 1.25,2.5 N N N I N N
5 -10.4% (6) 12.8% (2) 1288.1 1.25,2.5 Y N N I Y Y
19 10.2% (7) 4.8% (11) 1346.0 1.25,2.5 N Y N I Y N
31 -7.3% (8) 10.2% (5) 24194.7 1.25,2.5 Y Y N W N N
27 -6.0% (9) 4.3% (12) 12918.9 1.25,2.5 Y Y Y W N Y
43 5.0% (10) 9.0% (7) 2112.0 1.25,5.0 Y Y N W N N
4 3.9% (11) 12.9% (1) 2545.2 1.25,5.0 N Y N I Y N
35 -2.2% (12) 9.8% (6) 2095.1 1.25,2.5 Y Y Y I N N
30 -0.6% (13) 10.5% (4) 5192.5 1.25,2.5 Y Y N W Y Y
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Table 2.9: Statistical significance of nodule properties for group B (Wilcoxon
rank sum test)
Bias Variation
SD 0.231 0.308
CC 0.260 0.604
A 0.513 0.103
N 0.260 0.260
M 0.836 0.366
S 0.833 0.284
PC 1.000 0.692
Table 2.10: Bias and variation for group C (small change) and associated nodule
properties
ID Variation (rank) Vol.1 (mm3) CC A N M S PC
8 23.5% (1) 48.5 N Y N W N N
29 10.5% (2) 28.4 N N N W N N
32 10.2% (3) 39.5 N Y N W N N
42 9.0% (4) 326.8 N Y N I Y N
41 8.3% (5) 485.4 N Y N I Y N
37 8.2% (6) 1089.7 N Y N I N N
25 8.1% (7) 573.6 N Y N W N N
7 7.2% (8) 107.4 N N N W N N
47 5.9% (9) 854.9 N N N I Y N
10 5.9% (10) 731.3 N N N I N N
16 5.2% (11) 188.9 Y N N W N N
9 5.0% (12) 7025.3 N Y N W N N
2 3.8% (13) 1841.1 N Y N W N N
40 3.7% (14) 573.7 N Y N W N N
34 3.7% (15) 101.8 N N N W N N
48 3.0% (16) 356.7 N N N W N N
46 2.1% (17) 66.7 N N N W N N
38 1.6% (18) 1258.1 Y N N W N N
45 1.5% (19) 484.3 N N N W N N
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Table 2.11: Statistical significance of nodule properties for group C (Wilcoxon
rank sum test). Properties that were the same for all nodules in the group are
indicated with a “-”.
Variation
CC 0.259
A 0.050
N -
M 0.151
S 0.198
PC -
2.5 Discussion
This study was the first to compare different automated nodule size change
measurement methods on the same set of pulmonary nodules. Thanks to par-
ticipation by several research groups, a total of eighteen different methods were
represented in this study. From these measurements, we can make some obser-
vations about the performance of automated methods in general and determine
some of the factors affecting size measurement.
2.5.1 Repeat measurement behavior
Zero-change datasets have been used in many previously published studies to
quantify nodule size measurement variability. This dataset was represented by
the nodules in group A. The variation between the methods, measured by the
median MAD of 0.0408, indicated low variation between the methods. The 85%
confidence interval of the absolute medians across methods (i.e., omitting the
two largest cases) was 0.266 or a 26% volume change, which compares favorably
to the variation reported by previous published studies of approximately 20%.
The bias from the true zero value of size change provides some insight into
the accuracy of the size change measurement. For group A, the bias, as repre-
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sented by the median absolute median, was 0.0554, which is a large deviation
from zero. The non-zero bias is also apparent in the box plot for group A in
Figure 2.6; for 8 of the 14 cases, the interquartile range (IQR) did not include
zero. Therefore, there is evidence of a systematic bias introduced by the scan-
ner/nodule combination for these cases.
To examine the variation due to the nodule and/or scanner, the median
MAD was computed across nodules instead of across methods. The value of
0.0700 was larger than the median MAD computed across methods; thus, the
variation due to the nodule/scanner is larger than the variation due to the
methods. In addition, the median of the absolute medians, which measures
the bias, was lower, 0.0202, suggesting that any bias that exists is due to the
nodule/scanner and not the method.
2.5.2 Impact of change in CT slice thickness
One parameter that sometimes varies between scans when making a size change
measurement is the slice thickness. Comparing the results of the methods on the
nodules in group A, where the scans had the same slice thickness, and group B
where there was a change in slice thickness, provides an indication of how the
size change measurement is affected in such a scenario. The size change mea-
surements across the different methods in group A for all the methods were in
agreement (p = 0.81 using the Friedman test), that is, no method was signifi-
cantly different from any other method. In contrast, the size change measure-
ments for group B, where there is a change in slice thickness, were significantly
different between the methods (p < 0.01).
To determine if the variation is greater in group B, the median absolute de-
viation (MAD) was computed for each nodule in group A and group B and the
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Wilcoxon rank-sum test was performed. The variation was higher in group B
than group A (p < 0.01); with p = 0.05, the variation is 35% higher in group
B than group A. We also observe from Figure 2.10b that there is a greater dis-
persion in the IQR of the volume measurement for the thicker slice scan of the
phantom nodule (131.01 mm3 vs. 207.79 mm3) which is consistent with the
above results.
2.5.3 Variation of methods in presence of change
While the zero-change datasets enabled measurement of variation and bias of
the methods, the results may differ when nodules with actually change are con-
sidered. To determine if the behavior of the methods was similar, the variation
in measurements on the group C nodules (which had actual change) were com-
pared to the variation in group A. As before, the variation was measured by the
median of the median of absolute deviation (MMAD). The MMAD values for
group A and the small change cases in group C were 0.0408 and 0.0655 respec-
tively. These numbers are fairly similar and suggest that the results obtained
from a zero-change dataset capture similar behavior of a dataset with a small
amount of change.
There were three nodules in group C that exhibited a large change in size.
For these nodules, there was an increased variation between the methods (MMAD
of 0.4446). Although the number of cases was too small to perform statistical
analysis, with larger size changes, there is a greater possibility of disagreement
between the methods.
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2.5.4 Comparison of volume estimation
In this study, the measurement of interest was size change, and not the actual
size of the nodule, but the participants were requested to provide volume mea-
surements to enable a comparison. For the 12 methods that provided volume
information, the variation in the size change measurement was compared to the
volume measurements for group A and the small change subset of group C. The
Friedman test was performed to determine if the methods were in agreement.
In group A, there was no significant difference between the size change mea-
surements of the methods (p = 0.92), but there was significant disagreement
between the volume measurements of the methods (p < 0.01). For the small
change subset of group C, again there was no significant difference between
the size change measurements of the methods (p = 0.97)), but significant dis-
agreement in the volume measurements (p < 0.01). These results indicate that
conclusions drawn from size measurements may not apply to size change mea-
surements; one possible explanation is that a bias in size measurement between
methods might be neutralized when computing size change.
2.5.5 Impact of automation level and algorithm type
This study included algorithms with varying approaches to nodule growth rate
measurement, and this allows for observations about the general approaches,
such as how does the level of automation affect the performance, and is one ap-
proach significantly better than the others? Methods which require less human
intervention may not be able to correctly measure all nodules, leading to catas-
trophic errors in measurement, but for those nodules that are correctly mea-
sured, the performance should be better. Different approaches to growth mea-
surement may have different tradeoffs that only become apparent in compari-
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son to other methods. The analysis of the methods was based on their number
of outlier measurements compared to the other methods.
There was no clear correlation between the level of automation of a given
method and how it compared with the other methods. The two methods with
zero outliers were the Gifu and NYU-HYBA methods, which represented the
two extremes of automation. While the Gifu method required only a seed point,
the NYU-HYBA method required boundary modification on a majority of cases.
There were six methods with one outlier each, and the level of automation for
these methods ranged from one to six. Thus, based on these 18 methods, the au-
tomation level of a method did not correlate with its performance in this study.
There were several different categories of algorithms, but image filtering
with partial voxel correction (IFP) methods seemed, as a group, to have the
fewest number of outliers; the highest number of outliers for an IFP method was
2, compared with 9 for image filtering (IF) methods and 13 for other methods.
However, there were IF methods and other methods which had low numbers of
outliers, so we can not say that one specific approach is better than another.
2.5.6 Scan and nodule characteristics that influence bias and
variation
Determining the impact of nodule characteristics on the measurement of size
change has implications for interpreting the results of automated methods and
might be used to determine a level of confidence in the measurement. One pre-
vious study by Wang et al. (2008) [49] found that nodule morphology, location,
and size all influenced the measurement variability of an automated method.
In this study, we considered four possible sources of variation: scanner param-
69
(a) (b)
Figure 2.11: Example of a nodule from group A (zero-change, same slice thick-
ness) with a three slice difference between the first scan a) and the second scan
b)
eters, margin sharpness, presence of spiculations, and the presence of vessel
attachments.
In group A, the three nodules with the greatest bias all appeared on a differ-
ent number of slices on the two scans, with as much as a three slice difference
between scans. The significance of this observed effect from the difference in
slices was confirmed with p = 0.008. Two of the three nodules with the great-
est variation had a difference in the current used in the two scans; these two
nodules were also among the four nodules with the greatest bias. The change
in current was almost statistically significant, p = 0.055. None of the other
characteristics had statistically significant effects on either the bias or variation.
Although the characteristics were only tested individually for statistical signif-
icance, spiculations in conjunction with a ill-defined margin tended to increase
the variation, with the second, fourth, and sixth nodules with the highest varia-
tion having both characteristics.
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It was difficult to find any clear trends in the data for group B, with no char-
acteristics having any statistically significant effect on either the bias or varia-
tion. The difference in slice thickness seemed to dominate over all other charac-
teristics, although there was no statistical difference between the nodules with
1.25 mm and 2.5 mm scans and those with 1.25 mm and 5.0 mm scans.
In group C, since the true size change was unknown, the bias could not be
computed. The presence of attachments was the only significant effect (p =
0.05) on the variation. This is most likely because the algorithms all have differ-
ent approaches to segmenting sections of the nodule that are attached to other
structures; the presence of attachments was not significant in groups A or B due
to the lack of nodules without attachments in those groups.
2.5.7 Future extensions for VOLCANO
Although this is the largest study of automated methods for measuring the size
change of pulmonary nodules to date, there are many opportunities for extend-
ing this work in the future. The number of nodules and number of methods,
though large, was not sufficient to draw statistically significant conclusions on
the individual methods or on nodule characteristics; expanding the dataset and
gathering results from more automated methods would allow for more statis-
tically significant conclusions. In expanding the dataset, scans from additional
manufacturers should be included to determine if that has an effect; all of the
scans in this study were acquired on scanners from the same manufacturer (GE
Healthcare). Finally, future studies could provide the entire CT scan for analysis
– in this study, the CT scans were clipped in the axial direction to both reduce
the amount of data to be distributed and because some cases, since this was a
retrospective study, did not have CT scans of the entire lung region. Some au-
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tomated methods were developed with the assumption that many more image
slices would be available, and these methods may perform non-optimally with
this data.
2.6 Summary
An important consideration when developing a new algorithm how it performs
relative to previous methods. Addressing this has been problematic in the past,
due to the use of different datasets and evaluation methods. With this study, a
uniform dataset and evaluation methodology have been established to evaluate
automated nodule size measurement methods. The framework now exists to
both evaluate new methods and to develop further studies.
Size change measurements made on 50 nodule image pairs were reported
for 18 different methods. The analysis of the results showed (a) that there was
no statistical difference between the methods on scans of the same slice thick-
ness, (b) that there was a statistical difference in the methods when the scan slice
thickness is changed, and (c) that the behavior of the methods for nodules with
a small real change in size was similar to that for the zero-change data. The
last point has implications for the validity of using zero-size change datasets for
evaluating nodule measurement performance. Both the techniques used by the
methods and the amount of automation did not have a large effect on the per-
formance of individual methods. Finally, the nodules included in the dataset
spanned a wide variety of scanner parameters and morphology. In group A,
nodules that appeared on differing numbers of slices tended to have larger bi-
ases, and in group C, nodules with attachments had higher variation than nod-
ules without attachments. The other nodule characteristics did not have a clear
correlation with the amount of variation or bias for the methods.
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For 12 of the methods, volume measurements were provided in addition to
the size change measurements. The volume measurements did show a statisti-
cal difference between methods; therefore, caution is needed when extrapolat-
ing from studies that focus only on volume estimation when size change is the
intended task.
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CHAPTER 3
IMPROVED NODULE VOLUME MEASUREMENT REPEATABILITY
USING MOMENT-BASED Z-COMPENSATION
A novel method has been developed to improve volume measurement re-
peatability by compensating for additional variation in the axial (z) dimension
compared to the in-plane (x and y) dimensions [62]. CT images are usually
anisotropic, having a lower resolution in the z-dimension compared to the x-
and y-dimensions. Furthermore, it is possible that the CT image formation pro-
cess (acquisition and reconstruction) may result in some increased geometric
distortion with respect to the z-dimension, due to additional challenges from
the use of helical, multi-detector acquisition that require more complex recon-
struction algorithms. This may account for some of the observed change in size
of the zero-change nodules in the VOLCANO challenge in spite of the lack of
any physical change in the nodule, as discussed in the previous chapter. A z-
compensation (ZCOMP) algorithm which is specifically designed to accommo-
date such variation when estimating nodule size and change in size is presented
and evaluated in this chapter. The ZCOMP algorithm is based on a robust esti-
mate of the nodule size using image moments that are invariant to z-dimension
linear distortion (lengthening or shortening) but not x or y variations. This
method provided a reduction in variability, compared to a volumetric segmen-
tation method, on a dataset of zero-change nodules.
3.1 Z-variation compensation model
The underlying assumption of the z-compensation algorithm is that the mea-
surement in the z-dimension is less reliable than the measurements in the other
dimensions. By taking this into consideration when estimating the volume of
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Figure 3.1: Diagram of 2D nodule with a) no distortion and b) small distortion
in the z-dimension. The distortion increases the apparent size of the nodule.
a nodule, we can reduce the measurement variability. Consider a 2D image
(x and z dimensions) of a nodule region shown in Figure 3.1 for which there
exists a small but linear distortion in the z-dimension. To accurately measure
the growth in a time-separated pair of such images, we derive a method that
compensates for the distortion. Our approach is based on two assumptions:
1. Uniform isotropic growth of the nodule
2. Linear distortion in one dimension
The uniform growth assumption allows for the measurement of the growth of
the entire nodule from the change in one of the dimensions, and the assumption
of linear distortion provides a measurable model that we can analyze.
Using these two assumptions, a model can be derived. Let us begin with a
2D square that, in one case, grows uniformly in both dimensions by a factor α,
but in the second case, grows in one dimension by α and in the other dimension
by β. This is illustrated in the digram in Figure 3.2.
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Figure 3.2: Illustration of an object with a) an original size of w2 that grows b)
uniformly to α2w2 or c) non-uniformly to αβw2
The original area of the square is w2. It grows uniformly to α2w2 and non-
uniformly to αβw2. In the uniform growth case, the growth ∆u is:
∆u =
A2 − A1
A1
=
α2w2
w2
− 1 = (α2 − 1)
In the non-uniform growth case, the growth ∆n would be:
∆n =
A2 − A1
A1
=
αβw2
w2
− 1 = (αβ− 1)
which differs from the uniform case. We would like the growth to be inde-
pendent of any distortion in a single dimension, and for this, we use image
moments.
3.1.1 Moment analysis of an image region
One method to measure the size of an object in an image is via image moments.
Moment analysis of images has been used for various tasks including such di-
verse applications as shape characterization for the identification of airplanes
[63], nodule characterization algorithms [64, 65], and morphological character-
ization of intracranial aneurysms [66]. The general equation for moments of
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order p + q for a two-dimensional image is:
mpq =
ˆ
x
ˆ
z
xpzq f (x, z) (3.1)
where x and z are coordinates in space and f (x, z) is the image function. A 2D
image is composed of discrete voxels, so the discrete version of Equation 3.1 is:
mpq =∑
x
∑
z
xpzq f (x, z) (3.2)
where x and z are the voxel coordinates and f (x, z) is the intensity of the voxel.
For a binary image, f (x, z) is either 0 or 1, which results in the computation of
geometric moments – the moments are computed on the geometric form of an
object, where only the pixel locations belonging to the object are considered and
not the intensity. Note that this function is sensitive to the location of the region
under consideration (e.g. if the same region is shifted ten pixels in the positive
x-direction, it would have a larger m10 moment). This is undesirable since the
same object in different locations should, for the purpose of size measurement,
result in the same value, assuming no change in size. Location invariance of the
moment values is achieved by computing the moments with the index origin at
the center of mass (COM) of the binary object region according to the following
expression:
µpq =
ˆ
x
ˆ
z
(x− x¯)p(z− z¯)q f (x, z)dx dz (3.3)
which in the discrete image domain is
µpq =∑
x
∑
z
(x− x¯)p(z− z¯)q f (x, z) (3.4)
where the COM is given by (x, z): x¯ = m10m00 and z¯ =
m01
m00
. Note that, from the
moments, common properties of the image may be derived. For example, the
number of voxels in the segmentation is given by µ00 = ∑x ∑z f (x, z). The
following section will show how image moments can be used for estimating the
size of objects.
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3.1.2 Compensation for one-dimensional distortion with image
moments
Image moments provide a framework that can be used to estimate the size of
an object in the presence of a distortion in a single dimension. We shall begin
our discussion by analyzing the situation presented earlier in Figure 3.2. The
original size of the square, Figure 3.2a, has a central moment µpqA . The increase
in size of the object in Figure 3.2b can be represented as a scaling of the original
image, that is, fB(x, z) = fA( xα ,
z
α ) . This leads to the expression for the central
moment in the presence of scaling:
µpqB =
ˆ
x
ˆ
z
xpzq f (
x
α
,
z
α
) dx dz (3.5)
which, after substituting x′ = xα and z
′ = zα becomes
µpqB =
ˆ
x
ˆ
z
(
αx′
)p (
αz′
)q
α2 f (x′, z′) dx dz = αp+q+2µpqA (3.6)
Following the same substitutions, the object with non-uniform growth in Figure
3.2c has the central moment
µpqC = α
p+1βq+1µpqA (3.7)
The goal is to have an estimate of the size that will be invariant to the non-
uniform growth β. This is accomplished if we define the size to be
S2D = φ
µ20
µ00
(3.8)
where φ is included as an unknown scaling factor which may not be necessary.
Equation 3.8 provides the same size estimates for the the uniform growth case
Suni f orm = φ
α4µ20A
α2µ00A
= φα2
µ20A
µ00A
(3.9)
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and the non-uniform case
Snon−uni f orm = φ
α3βµ20A
αβµ00A
= φα2
µ20A
µ00A
(3.10)
Since the size estimates are the same, the growth estimates ∆ for both of these
cases are the same as well and are:
∆ =
SB2D
SA2D
− 1 =
φα2
µ20A
µ00A
φ
µ20A
µ00A
− 1 = α2 − 1 (3.11)
which also matches the growth computed from the area A of the rectangles,
assuming uniform growth:
∆u =
AB
AA
− 1 = αw · αw
w · w − 1 = α
2 − 1 (3.12)
In calculating growth, the scaling factor φ can be eliminated because it is present
in both the numerator and denominator, but this does not mean that the size S
is equivalent to the size that would be computed from the dimensions of the
object. The scaling factor φ can be determined from the moment expressions
(the object is assumed to be centered at the origin so that the COM is located at
(0,0), and the object is bounded from −w2 to w2 ):
µ20 =
ˆ w/2
−w/2
ˆ w/2
−w/2
x2 dx dy =
ˆ w/2
−w/2
1
3
((w
2
)3 − (−w
2
)3)
dy =
w3
12
w =
w4
12
µ00 =
ˆ w/2
−w/2
ˆ w/2
−w/2
dx dy =
ˆ w/2
−w/2
w dy = w2
so that, for S to be equivalent,
φ = 12
This two-dimensional moment-based measure of size makes use of all the avail-
able image data and is unaffected by a distortion in a single dimension.
The above analysis can be extended to three-dimensions. In 3D, we assume
that the measurement in the z-dimension may have distortion, while the mea-
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surements in the x- and y-dimensions are reliable. Again, we use moment anal-
ysis to compute the size of the object, and the equation for a discrete, central 3D
moment is:
µpqr =∑
x
∑
y
∑
z
(x− x¯)p(y− y¯)q(z− z¯)r f (x, y, z) (3.13)
where x, y, and z are the voxel coordinates and f (x, y, z) is the intensity of the
voxel, and the COM is given by (x, y, z): x¯ = m100m000 , y¯ =
m010
m000
, and z¯ = m001m000 . As in
the two-dimensional case, the size in a single dimension is based on the second-
order central moment of the reliable dimensions, the x- and y- dimensions. The
size is computed now using the size in x and y, so the size is given by:
S3D = k
(√
µ200
µ000
·
√
µ020
µ000
)3/2
(3.14)
where k is a scaling factor,
√
µ200
µ000
is an estimate of the size in a single dimen-
sion, since S2D provides a two-dimensional size estimate, and the cube of the
square root of the product is done to compute the volume from measures in two
dimensions.
Having derived the expression for the 3D size (volume) that is independent
of the distortion in the z-dimension, we can now develop an algorithm to mea-
sure the size and size change of pulmonary nodules.
3.2 Pulmonary nodule growth measurement with Z-compensation
Based on the z-variation compensation model described in Section 3.1, an algo-
rithm was developed to measure pulmonary nodule growth. In a typical nodule
growth measurement algorithm, such as the algorithm described in Section 1.7,
the nodule is segmented on each scan, the volume computed by summing the
number of voxels in the segmented image of the nodule and multiplying by the
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voxel size to obtain the volume of the nodule, and estimating the growth rate
from the volume change. The z-variation compensation algorithm (ZCOMP),
on the other hand, calculates a surrogate measure of size based on the three-
dimensional moments of the image. ZCOMP has three primary steps:
1. Given a seed point within the nodule, segment the nodule on each scan to
obtain a binary representations of the nodule
2. Compute the zero and second order moments, µ200 and µ020, on each bi-
nary image of the nodule
3. Estimate growth based on the moment analysis of the nodule
Obtaining a binary representation of the nodule from a user-specified seed point
is accomplished by segmenting the nodule using the algorithm described in Sec-
tion 1.7 by Reeves et al. [23]. The algorithm provides a binary image represen-
tation of the nodule, from which the 3D moments are computed, as described
in Section 3.1.1. Finally, these moments are used to compute a surrogate growth
measure, which is further described in the next section.
3.2.1 Growth analysis from moments
A surrogate measure of pulmonary nodule growth is computed from the 3D
moment analysis of the binary image representation of the nodule. The quantity
of interest for growth analysis is the relative size difference:
RSD =
ST2
ST1
− 1
where S2 and S1 are the measured sizes (such as volume) on the second (T2)
and first (T1) scans respectively. Substituting Equation 3.14 into the above ex-
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pression yields the z-compensated relative size difference:
RSD =
(√
µ200
µ000
·
√
µ020
µ000
)3/2
T2(√
µ200
µ000
·
√
µ020
µ000
)3/2
T1
− 1
3.2.2 Derivation of scaling factor k
To compute the actual volume of the nodule, Equation 3.14 needs to be scaled
by a constant k, but since we are concerned with the relative size change when
calculating growth, k cancels out of the expression and we need not be con-
cerned with its value. However, to compare the volume estimates of ZCOMP
to the volume estimates of the segmentation method, we can derive k. For this
derivation, we will assume that, since nodules are roughly spherical, that the
shape will be a sphere of radius r. The continuous expression for the moment
will be used for the derivation. The equation for a sphere is:
x2 + y2 + z2 = r2 (3.15)
for a sphere of radius r. The continuous moment µ200 is:
µ200 =
ˆ
x
ˆ
y
ˆ
z
x2 f (x, y, z)dx dy dz (3.16)
To get the limits of the integral, we rearrange equation 3.15
z =
√
r2 − x2 − y2 (3.17)
and, to simplify the problem, we will only compute the integral for a quarter of
a sphere, so the limits on z are 0 ≤ z ≤ √r2 − x2 − y2. To determine the limits
on y, the projection of the sphere onto the xy plane is
y =
√
r2 − x2
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and again, since the integral is being computed for a quarter of a sphere, the
limits on y are 0 ≤ y ≤ √r2 − x2. Finally, the limits on x are −r ≤ x ≤ r .
Substituting these limits into equation 3.16 results in the integral
µ200 = 4
ˆ r
−r
ˆ √r2−x2
0
ˆ √r2−x2−y2
0
x2 dx dy dz
since f (x, y, z) is 1 within the integral. Solving the integral results in the follow-
ing:
µ200 = 4 · pi15r
5
Now we can substitute into equation 3.14, using the volume of a sphere as
V, and solve for k:
4
3
pir3 = k

√√√√ 4pir515
4
3pir
3
·
√√√√ 4pir515
4
3pir
3
3/2
= k
(√
r2
5
·
√
r2
5
)3/2
= k
(
r2
5
)3/2
= k
(
r3
5
√
5
)
Rearranging the equation to solve for k:
4
3
pir3 = k
(
r3
5
√
5
)
20
√
5
3
pi = k (3.18)
This scaling coefficient was validated using synthetically generated spheres.
A VisionX program, vgsphere, was used to generate spheres ranging in diam-
eter from 4.0 mm to 8.0 mm. The vgsphere program is capable of generating
spheres with partial voxel intensities. The output of vgsphere was thresholded
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Figure 3.3: Plot of volume change of a 4.0 mm synthetic sphere using the volu-
metric and z-compensation algorithms; the x-axis indicates the new diameter of
the sphere used to calculate ST2. In this synthetic case, both algorithms measure
the same amount of change.
to the same value as in the segmentation method described in Section 1.6, and
the volume change was computed relative to a 4.0 mm diameter sphere. The es-
timated volume change for the volumetric and z-compensation algorithms are
shown in the plot in Figure 3.3, with the residuals shown in Figure 3.4. For an
increase in nodule diameter to 5.0 mm, which corresponds to a relative volume
change of 0.988 or 98.8%, the z-compensation algorithm measured a change of
0.987 or 98.7%, a difference of only 0.1%. This small difference is attributable
to the imprecision from rounding errors in the sphere generation and floating
point representation and is not significant. ZCOMP was within 1% of the volu-
metric method up to a relative volume change of 7.25 (725%), and there was a
trend of increasing difference with increasing relative volume change, which is
negligible.
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Figure 3.4: Plot of residual relative volume change of the z-compensation al-
gorithm compared to the volumetric method on the baseline 4.0 mm diameter
sphere from Figure 3.3. These small residuals do not have any noticeable impact
on the measurement.
3.3 Experimental evaluation of z-compensation
The goal of the z-compensation method was to reduce the variability from the
additional uncertainty in the z-dimension while still being sensitive to actual
changes in the nodule size. An experiment to quantify this was developed using
nodules with repeat scans in the same session—since these nodules should have
no change, any non-zero measured change would be due to problems with the
scans or uncertainties in the measurement method. The relative size differences
(RSD) were measured for these nodules, and lower values of RSD indicate less
variation. The computed RSD were used to compute the interscan variability,
which is defined as the 95% confidence interval of the RSD. Given the mean, µ,
and standard deviation, σ, the 95% confidence interval of the RSD is:
(µ− 1.96 · σ, µ+ 1.96 · σ)
To evaluate the method, the RSD was computed for a dataset of 22 nodules
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with multiple scans taken within the span of a few minutes. To determine the
effect of varying slice thicknesses on the performance of the method, these 22
nodules were divided into two subsets of eleven nodules each. In the first set of
eleven cases, the scans were taken using the same slice thickness, with ten of the
eleven cases at 1.25 mm slice thickness and one at a slice thickness of 2.5 mm.
In the remaining eleven cases, scans were taken at different resolutions, with at
least one scan at a slice thickness of 1.25 mm. In three cases, the second scan
had a 5.0 mm slice thickness while eight had 2.5 mm. All cases had a nodule
of solid consistency, as determined by a radiologist, with at least two scans that
included the entire nodule. The mean size of the nodules in the dataset was 14.1
mm with a standard deviation (SD) of 5.6 mm. For the eleven cases with scans
of the same slice thickness, the mean size was 14.8 mm with a SD of 4.6 mm
while the eleven cases with scans of different slice thickness had a mean size
of 13.4 mm with a SD of 6.5 mm. A plot of the size distribution of the nodules
in the dataset is shown in Figure 3.5. Scans were obtained using either a GE
LightSpeed QX/i or LightSpeed Ultra scanner, using 120 kVp and a current in
the range of 40-250 mAs.
The standard volumetric method and ZCOMP were compared on the basis
of interscan variability, with a smaller interscan variability indicative of a more
consistent measurement.
3.4 ZCOMP evaluation results
The new ZCOMP method was compared to a previously published volumetric
method on the basis of interscan variability by Reeves et al. [23] described in
Section 1.6. Interscan variability is presented as the upper and lower bounds
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Figure 3.5: Size distribution of nodules in the ZCOMP evaluation dataset. The
value along the x-axis indicates the minimum size of nodules in the bin.
Table 3.1: Interscan variability of volumetric and moment-based methods
Interscan variability (%)
Dataset Volumetric method Moment-based method
Full (22 nodules) (-52.1, 30.1) (-34.2, 23.3)
Same slice thickness (11) (-24.0, 18.2) (-12.4, 12.7)
Mixed slice thickness (11) (-68.4, 30.2) (-46.5, 24.4)
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of the 95% confidence interval of the relative size difference of the cases in the
study. On cases with scans of the same slice thickness, which is comparable
to cases used in previously published studies, the volumetric method had an
interscan variability of -24.0% to 18.2%. The moment-based method had a lower
interscan variability of -12.4% to 12.7%. The full results are presented in Table
3.1, and were previously presented at SPIE Medical Imaging 2009 [62].
As the conventional method of expressing pulmonary nodule size is in di-
ameter, the interscan variability can be converted to a relative size difference;
these values are included in Table 3.2. As an example of the actual impact on
size measurement the interscan variability may have, the size difference corre-
sponding to the confidence intervals of the interscan variability in Table 3.1 are
shown in Table 3.3 for a 10 mm nodule. Note that despite a large interscan vari-
ability in relative volume difference, the difference in size on a 10 mm lesion is
less than 1 mm for cases of the same slice thickness.
3.5 ZCOMP Discussion
In the ideal case, a nodule growth measurement method would have 0% vari-
ability on a zero-change scan, since the nodule is not changing in size. Lower
Table 3.2: Interscan variability presented as relative size difference
Interscan variability (size) (%)
Dataset Volumetric method Moment-based method
Full (22 nodules) (-21.8, 9.2) (-13.0, 7.2)
Same slice thickness (11) (-5.7, 8.7) (-4.1, 4.3)
Mixed slice thickness (11) (-31.9, 9.2) (-18.8, 7.5)
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Table 3.3: Interscan variability presented as size range for a 10 mm nodule
Interscan size variability (mm)
Dataset Volumetric method Moment-based method
Full (22 nodules) (7.8, 10.9) (8.7, 10.7)
Same slice thickness (11) (9.1, 10.6) (9.6, 10.4)
Mixed slice thickness (11) (6.8, 10.9) (8.1, 10.8)
values of interscan variability indicate a more reliable volume measurement,
which is critical when computing the volume change. This variability can then
be used to establish error bounds on the measurement precision of the method.
Previous studies of other methods have found interscan variability of approx-
imately (-20%, 20%) using scans of the same slice thickness, as summarized in
Section 1.4.4; our standard volumetric method, on the eleven nodules with scans
of the same slice thickness, performed similarly with a variability of (-24.0%,
18.2%). ZCOMP reduced the variability to (-12.4%, 12.7%). As described in Sec-
tion 1.4, by reducing the measurement variation, we can compute more accurate
growth estimates, in turn improving clinical decision making.
Often, scans of a patient may have been taken at different resolutions due
to changes in protocol or scanners. To assess performance for such a case,
this study included zero-change scans with different slice thicknesses. Both
methods performed worse on the eleven nodules with scans of different slice
thicknesses, with the volumetric method interscan variability increasing to (-
68.4%, 30.2%) and the moment-based method interscan variability increasing to
(-46.5%, 24.4%). Although ZCOMP had better performance than the volumet-
ric method, the intervals for both methods are still too large to be useful. This
result suggests that pulmonary nodule growth assessment requires scans with
the same slice thickness for the most accurate measurement.
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Although the measurements from ZCOMP had a lower interscan variability
overall, the volume difference measured by the algorithm was not consistently
lower on every case. These observations indicate that ZCOMP is not simply
less sensitive to changes in general. The z-compensation algorithm measured a
higher relative volume difference than the volumetric method on ten cases, but
the difference between the two methods was small, with an average difference
between the two methods of 5.8%. These cases were divided nearly equally di-
vided among the same-slice thickness (4) and mixed-slice thickness (6) cases and
were generally the cases with small volume differences. On the other twelve
cases where ZCOMP measured a lower relative volume difference than the vol-
umetric method, ZCOMP had much lower values; on average, ZCOMP had
measurements that were 14.0% lower. These cases tended to be those nodules
with large volume differences, where ZCOMP was closer to the ideal measure-
ment of 0.
All of these nodules were zero-change nodules, yet most of the nodules had
measured non-zero change. For many of the nodules, the appearance of the
nodule on one scan was different than on the subsequent scan; in some cases,
the difference was great enough to cause a large difference in volume between
the two scans, while in others the volume difference was minimal. One case
with a large difference in volume is shown in Figure 3.6. In this case, one scan
was acquired with a slice thickness of 1.25 mm while the other scan was ac-
quired with 5.0 mm; the relative volume difference computed by the volumetric
method was 37.8% while the relative size difference computed by ZCOMP was
43.8%, with the larger volume measured on the first scan. In another case, even
though the scans were obtained at different slice thicknesses, the volume change
90
(a) (b)
(c) (d)
Figure 3.6: Example of a case with scans of the different slice thickness (1.25 mm
top, 5.0 mm bottom) and high interscan variability. a) Montage of several slices
through the nodule on the first scan, b) segmentation of the nodule on the first
scan where white voxels are those belonging to the nodule, c) several slices on
the second scan, and d) segmentation on the second scan. Scans are not to the
same scale.
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(a) (b)
(c) (d)
Figure 3.7: Example of a case with scans of the different slice thickness (1.25
mm top, 2.5 mm bottom) and low interscan variability. a) Montage of several
slices through the nodule on the first scan, b) segmentation on the first scan with
voxels part of the nodule indicated in white, c) several slices on the second scan,
and d) segmentation on the second scan. Scans are not to the same scale.
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(a) (b)
(c) (d)
Figure 3.8: Example of a case with scans of the same slice thickness and high
inter-scan variability. a) Montage of several slices through the nodule on the
first scan, b) segmentation on the first scan, c) several slices on the second scan,
and d) segmentation on the second scan. Note that there appears to be an extra
slice between the two scans.
was small, as in Figure 3.7. For this case, the volumetric method had a volume
difference of 2.8% compared to 13% for ZCOMP. Even in cases with scans of the
same slice thickness, there was sometimes a marked difference in the appear-
ance of the nodule between the two scans, as illustrated by the case in Figure
3.8. The nodule appears on an additional slice in the second CT scan, which is
reflected in the segmentation shown on the right side of the figure. In this case,
ZCOMP was less affected by the additional slice than the volumetric method,
with a volume difference of 12.6% for ZCOMP and 30.3% for the volumetric
method.
Another possible source of some of the observed variations may come from
the sizes of the nodules themselves, which may have resulted in a relationship
between the size of the nodule and the measured size difference. Linear re-
gression was performed to determine if there was any correlation between the
volume and measured volume change; neither method showed a significant re-
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Figure 3.9: Scatter plot of measured volume change versus the initial volume
of the nodule for a) volumetric measurement method and b) moment-based
method. Neither method has a significant dependency on the size of the nodule.
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lationship, with the volumetric method having a Spearman’s rank correlation
coefficient ρ = 0.14 and ZCOMP having a ρ = 0.51. This can be seen in a scatter
plot of the data in Figure 3.9. Based on the lack of correlation between size and
volume change, neither method has a variation dependence on the size of the
nodule, which agreed with previously published studies [46].
Overall, the results of the z-compensation algorithm showed a promising
reduction in interscan variability compared to the volumetric method. This de-
crease has the potential to allow for better decision making by radiologists, and
the algorithm can be applied to any segmentation-based measurement method.
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CHAPTER 4
NODULE GROWTH RATE MEASUREMENT FROM DENSITY CHANGE
The majority of current systems for measuring pulmonary nodule growth
rate compute the growth rate by segmentation-based volume measurement meth-
ods. These methods segment the nodule from each computed tomography (CT)
scan and calculate the volume from the segmented image. The process of seg-
mentation entails assigning a class to each voxel: nodule or non-nodule. How-
ever, this task is difficult for many nodules with complex shapes where there is
uncertainty as to whether a voxel should be considered part of the nodule.
To address this issue, an alternative approach was developed to measure
nodule growth that takes into account the radiodensity of the nodule and does
not require explicit segmentation [61]. Instead, this method uses the mean den-
sity change of a fixed size region containing the nodule as a surrogate mea-
sure of nodule growth. The mean density change is computed after applying a
weighting function to reduce the influence of non-nodule structures far from the
nodule center. This method has the advantage of being able to measure nodules
with a complex appearance that may cause a segmentation-based method to
fail, such as the nodule in Figure 4.1. This method was evaluated by comparing
performance with our direct volumetric segmentation method. To accomplish
this evaluation, we used three nodule image databases consisting of: a) zero-
change, b) malignant, and c) benign nodules.
4.1 Pulmonary Nodule Density Change Model
To provide a basis for the measurement of nodule growth rate from the density
change, we define a model for the nodule that consists of the following:
• The mean density in a region is proportional to the amount of cells in that
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Figure 4.1: Central slice of a nodule exhibiting a complex shape which may be
difficult to segment
region
• Nodules have an approximately spherical shape
• The majority of growth occurs at the boundary of the nodule and lung
parenchyma
• Non-nodule structures tend to be located at the periphery of the nodule
and do not change in size over time
Computed tomography scans have calibrated pixel values that are proportional
to the photon density at that location. At the microscopic sub-pixel level, the
material in the lung may be classified into two basic types with different den-
sities – air and soft tissue. If we scale the intensity of the image such that the
value for air is 0 and the value for soft tissue is 1, then the density of the region
of interest (ROI) will indicate the portion of the ROI that is soft tissue. On a sub-
sequent scan, when a nodule has increased in size (by adding more cells and
displacing air), the measured density of the same ROI will also increase.
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T1
T2
Figure 4.2: Simple model of an isolated nodule surrounded by air. The volume
of the nodule grows from VT1 to VT2.
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Figure 4.3: Sampled intensities along a line for the simple, isolated nodule
model
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Let us begin with the simple case of an isolated nodule surrounded only
by air and a non-attached, high-intensity structure, as illustrated by the two
dimensional region of interest in Figure 4.2. The initial volume of the nodule is
VT1 on the first scan and increases to VT2 on the second scan. The intensity of air
is given the value 0, while the voxels of the nodule have an intensity of 1, and
the shades of gray only serve to indicate different regions, not intensities. The
other structure in the scan is comprised of soft-tisue with an intensity of 1 and
is separate from the nodule.
While the mean density could be computed over the entire region of interest,
it would be desirable to exclude as many non-nodule voxels as possible to en-
sure that the mean density change will reflect only the change in the nodule. To
accomplish this, we introduce the idea of a weighting function, w(x, y, z), which
applies a weight to every voxel in the image. In the simplest case, a uniform
spherical weighting function could be used that weights voxels located within
the sphere as 1 and voxels outside the sphere as 0:
wuniform(x, y, z) =
r
∑
x=−r
√
r2−(x−x0)2
∑
y=−
√
r2−(x−x0)2
√
r2−(x−x0)2−(y−y0)2
∑
z=−
√
r2−(x−x0)2−(y−y0)2
1
where the limits are derived from the equation for a sphere centered at x0, y0,
z0, (x− x0)2 + (y− y0)2 + (z− z0)2 = r2. In Figure 4.2, the weighting function
is illustrated as a circle co-located with the nodule center, with a radius large
enough to encompass the entire nodule. The radius of the circle is shown to be
larger than the nodule to account for uncertainty in the estimation of the nodule
size. Sampling the intensities along the dashed line in Figure 4.2 yields the plot
shown in Figure 4.3, with the x-axis representing the distance along the line.
The uniform weighting function includes some voxels of air on both sides
of the nodule, which represent the uncertainty in the nodule size. Note that
including regions of air will not affect the mean weighted density. The mean
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weighted density is then given by
D =
1
NROI
∑
x
∑
y
∑
z
w(x, y, z) · f (x, y, z)
where NROI is the number of voxels in the ROI and f (x, y, z) is the voxel in-
tensity (1 for soft tissue and 0 for air), and w(x, y, z) is the weighting function,
which for this example is the uniform spherical weighting function given above.
This simplifies to
D =
Nnodule
NROI
where Nnodule is the number of voxels in the nodule. Thus, the relative density
change (CD) of the nodule from the first scan to the second scan is
CD =
DT2 − DT1
DT1
=
NT2
NROI
− NT1NROI
NT1
NROI
=
NT2 − NT1
NT1
where NT2 and NT1 are the number of voxels comprising the nodule on the
second and first scans respectively. If the nodule grew by α between the first
and second scans (NT2 = αNT1), then the CD is
CD =
αNT1 − NT1
NT1
= (α− 1) (4.1)
This can be compared to the relative volume change (CV) given by
CV =
VT2 −VT1
VT1
where VT2 and VT1 are the volumes of the nodule on the second and first scans.
Note that the volume of the nodule is the volume of a voxel, s, multiplied by
the number of voxels. If we again assume the nodule grew by α, then the RVC
simplifies to:
CV =
sαNT1 − sNT1
sNT1
= (α− 1) (4.2)
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T1
T2
Figure 4.4: Model of nodule region with an attached structure surrounded by
air. The nodule increased in size from VT1 to VT2.
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Figure 4.5: Sampled intensities along line for a nodule with an attached struc-
ture. The ideal weighting function from Figure 4.3 is shown by the dashed line
in red. Note that the boundaries of the nodule and the attached structure can
not be determined from the intensity alone; the gray dashed lines only serve for
reference.
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Figure 4.6: Sampled intensities along a line for a nodule with an attached struc-
ture. The weighting function, shown by the gray (orange) dotted dashed line,
de-emphasizes voxels far from the nodule center.
which is the same expression as the RDC for this case of an isolated nodule.
Many nodules have attached structures, such as blood vessels or the chest
wall, that are similar in intensity to the nodule tissue; to model this situation, let
us add an attached structure to the ROI and determine its effect on the RDC. In
Figure 4.4, the nodule now has a large attached structure. Since the structure is
of similar intensity as the nodule, it will be difficult to separate the nodule from
the attachment. This is illustrated by the plot in Figure 4.5, which represents
the intensities along the dashed line in Figure 4.4. If we use the ideal weighting
function from Figure 4.3, some of the voxels from the attached structure will be
included in the mean weighted density calculation, due to the uncertainty in
the nodule size. Using the same parameters as for the simple model without
an attachment, assume that the weighting function includes some number of
voxels from the attached structure proportional to the number of voxels in NT1,
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Natt = βNT1, and that the number of voxels in the attached structure within the
ROI does not change between the first scan and the second scan. The density on
the first scan becomes
DˆT1 =
NT1 + Natt
NROI
=
NT1 + βNT1
NROI
= DT1 · (1+ β)
and on the second scan
DˆT2 =
NT2 + Natt
NROI
=
αNT1 + βNT1
NROI
= DT1 · (α+ β)
The resulting relative density change, CˆD, with the inclusion of non-nodule vox-
els, is given by:
CˆD =
DˆT2 − DˆT1
DˆT1
=
DT1 · (α+ β)− (DT1 · (1+ β))
DT1 · (1+ β) =
α− 1
1+ β
(4.3)
From Equation 4.3, the CˆD will be decreased compared to the CD for the simple
model in Equation 4.1. The difference can be illustrated by substituting values
into the expression for α and β. Consider a nodule that increases 20% in volume
from the measurement on the first scan to the second scan, that is, VT2 = 1.2VT1,
or NT2 = 1.2NT1. If the ROI includes voxels from the attached structure that
correspond to 10% of the nodule volume, so that Natt = 0.1NT1, then the CˆD
would be
CˆD =
α− 1
1+ β
=
1.2− 1
1+ 0.1
=
0.2
1.1
= 0.182
which is lower than the actual volume change of 20%. This implies a reduced
sensitivity to nodule growth, with larger values of β resulting in smaller CˆD
values.
We wish to find α in the presence of β to obtain an accurate measure of
nodule growth. To mitigate the impact of attached structures, a non-uniform
weighting function can be used that decreases the weight of the attached struc-
tures. If we make the assumption that the attached structures will be far from
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the center of the nodule, then a weighting function such as the one illustrated in
Figure 4.6 can be used, which reduces the weight of voxels that are far from the
nodule center. This weighting function will decrease β proportionally by some
amount B, where 0 < B < 1 , but it will also decrease the value of α proportion-
ally by A. The relative density change with weighting (CDW), becomes:
CDW =
Aα− 1
1+ Bβ
An ideal weighting function would apply no weight (B = 0) to the non-nodule
structures and all the weight (A = 1) to the voxels belonging to the nodule.
This is difficult to achieve in practice, due to the uncertainty in the boundary
between the nodule and non-nodule soft tissue structures, but as long as A is
greater than B, applying a weighting function will result in a better estimate of
nodule growth. Using the previous example with a 20% change in the nodule
size, and attached structures that have a volume equal to 10% of the nodule
volume, the CDW is:
CDW =
Aα− 1
1+ Bβ
=
1.2A− 1
1+ 0.1B
If A = 0.99 and B = 0.1, then
CDW =
1.2 · 0.99− 1
1+ 0.1 · 0.1 =
0.188
1.01
= 0.186
which is slightly higher than the non-weighted case. Note that, if A is signifi-
cantly different than 1, the CDW value decreases substantially, so it is important
to select a weighting function that includes as many of the voxels within the
nodule as possible.
A 3D isotropic Gaussian weighting function was chosen for preliminary
study. The weight of a particular voxel was solely dependent on the distance
from the center of the nodule according to a Gaussian function, which was given
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Figure 4.7: Diagram showing an idealized nodule profile in 1D (dashed line)
with a Gaussian (solid line). The width of the Gaussian is selected to reduce the
impact of structures far from the nodule center while still including the entire
nodule.
by the following equation:
G(x, y, z, xc, yc, zc, σ) =
1
(2pi)3/2σ3
exp
(−(x− xc)2 − (y− yc)2 − (z− zc)2
2σ2
)
where xc, yc, and zc is the coordinate of the center of the nodule, and σ is the
standard deviation of the kernel. The components at the center of the nodule
have the greatest contribution to the mean density, and structures far from the
center have less of a contribution. A diagram illustrating an idealized nodule
intensity profile in 1D and a Gaussian function is shown in Figure 4.7.
A critical parameter of the Gaussian weighting function is the size, σ. If σ is
too small, the weighting function will apply a low weight to some voxels that
are part of the nodule, and as a result, it will not be very sensitive to changes
in the nodule size. However, if σ is too large, non-nodule voxels will have a
relatively high weight, and therefore will be included in the growth calculation.
Thus, the mean density was computed according to the following equation on
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both images:
M =∑
x
∑
y
∑
z
I(x, y, z)G(x, y, z, C2, S2)
Note that, unlike the mean density computed using a uniform weighting
function, the Gaussian-weighted mean density is not linearly related to the vol-
ume. Te determine the relationship, the expression for the Gaussian-weighted
mean density for a sphere was derived. Given a a sphere of radius r and inten-
sity A, and an isotropic Gaussian Gσ with a standard deviation of σ, the mean
density is:
M = A
˚
V
GσdV
=
R
A
ˆ
−R
dz
√
R2−z2ˆ
−√R2−z2
dy
√
R2−z2−y2ˆ
−
√
R2−z2−y2
dx Gσ(x, y, z)
To solve this expression, the rectangular coordinates are converted into spheri-
cal coordinates.
M = A
2pˆi
0
dθ
pˆi
0
dφ
Rˆ
0
dr
sin(φ)r2
(
√
2piσ)3
e−
r2
2σ2
=
A
2piσ2
2pˆi
0
dθ
pˆi
0
dφ sin(φ)
Rˆ
0
dr
r2√
2piσ
e−
r2
2σ2
=
A
2piσ2
2pˆi
0
dθ
pˆi
0
dφ sin(φ)
 Rˆ
0
r2 − σ2√
2piσ
e−
r2
2σ2 dr + σ2
Rˆ
0
1√
2piσ
e−
r2
2σ2 dr

=
A
2piσ2
2pˆi
0
dθ
pˆi
0
dφ sin(φ)
([
−rσ2 1√
2piσ
e−
r2
2σ2
]r=R
r=0
+
σ2
2
erf
(
R√
2œ
))
=
A
2piσ2
2pˆi
0
dθ
pˆi
0
dφ sin(φ)σ2
(
−R 1√
2piσ
e−
R2
2σ2 +
σ2
2
erf
(
R√
2œ
))
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Figure 4.8: Mean weighted density, computed theoretically and according to the
implemented algorithm, for simulated image data of spheres changing from 4
to 8 mm in diameter
M =
A
2pi
(
−R 1√
2piσ
e−
R2
2σ2 +
σ2
2
erf
(
R√
2œ
)) 2pˆi
0
dθ [− cos(φ)]φ=piφ=0
=
A
2pi
(
−R 1√
2piσ
e−
R2
2σ2 +
σ2
2
erf
(
R√
2œ
)) 2pˆi
0
dθ 2
=
A
2pi
(
−R 1√
2piσ
e−
R2
2σ2 +
σ2
2
erf
(
R√
2œ
))
[2θ]θ=2piθ=0
M = 2A
(
−R 1√
2piσ
e−
R2
2σ2 +
σ2
2
erf
(
R√
2œ
))
(4.4)
Since the expression for the mean weighted density M is comprised of the error
function(erf), the expression has no closed-form solution, though numerical ap-
proximations exist. To validate the developed code, the program was applied to
a series of images of spheres 4 to 8 mm in diameter. The images were generated
by a VisionX program, vgsphere, that generates a gray-level image of a sphere
taking into account partial voxels along the boundary. The generated spheres
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Figure 4.9: Residuals for theoretical - implemented algorithm for simulated
spheres of size 4 to 8 mm in diameter
had an intensity of 0HU. The 8 mm sphere was used to set the σ for the Gaus-
sian. The mean density computed from Equation 4.4 using GNU Octave [67]
was plotted with the mean density computed from the implemented algorithm
in Figure 4.8, with the residuals shown in Figure 4.9. The residuals were less
than one HU in all cases.
The next step was to assess the relationship between the measurements from
the mean weighted density and the nodule volume. Since the expression for
growth index and relative size change both involve the term S2S1 , where S indi-
cates the size determined by a given method, this was the quantity considered
in the analysis. The typical range of interest for measuring nodule growth is up
to a doubling in nodule volume. For the case of a nodule 4 mm in diameter, the
volume is 33.5 mm3, so doubling the volume to 67.0 mm3 results in a nodule
diameter of 5.0 mm, and halving the volume to 16.8 mm3 results in a nodule
diameter of 3.2 mm. Using the relative size computed from the mean density
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Figure 4.10: Comparison of relative size according to mean weighted density
and volume. Since the relative size computed using the mean weighted density
differs from the curve for the relative size computed from volume, a transfor-
mation function was necessary to make the values directly comparable.
directly (relative to a 4.0 mm diameter sphere) for the range of nodule diameters
of 3.0 mm to 5.0 mm results in the relationship shown in Figure 4.10. Nodules
with diameters less than 4.0 mm are considered to have decreased in size, while
larger than 4.0 mm have increased in size. The relative size computed from
the mean density varies differently with the nodule diameter than volume. Al-
though this does not have an impact on diagnostic performance, this makes it
difficult to directly compare the density change measurements with volume.
An expression for the relationship between the mean density change and
the volume change can be numerically estimated from the measurements in
Figure 4.10. Based on the plot, the data approximated a quadratic function in
the interval of interest:
RV = a · RD2 + b · RD+ c (4.5)
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Figure 4.11: Residuals of the density change compensated according to Equa-
tion 4.5 compared to volume change.
where RV = V2V1 and RD =
M2
M1
using the non-linear least squares algorithm in R
[68]. The coefficients were estimated to be a = 0.465, b = 0.449, and c = 0.085.
An expression without the intercept term c was also tested, but was found to
have a fit that was worse. Other, more complex expressions were tested, includ-
ing higher powers and exponential functions, and none resulted in statistically
significant lower error. The residuals of the new, adjusted mean density change,
are shown in Figure 4.11. The residuals are very small (less than 1 percent) in
the interval of interest.
4.2 Growth index from density (GID) method
Based on the nodule model described in Section 4.1, a method was developed
to measure nodule growth index from the change in density (GID). The major
steps of the GID method are shown in Figure 4.12. First, preprocessing of the CT
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Figure 4.12: Overview of growth index from density measurement algorithm
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scans was performed to select a region of interest around the nodule and gen-
erate an isotropic image. Next, the center and size of the nodule are estimated
from a manually specified seed point using an iterative optimization approach.
In the third step, the regions surrounding the nodule on each CT scan were reg-
istered. In the final step, a weighting function is applied to the region and the
mean density computed; this mean density is used as a surrogate for volume in
the computations for growth rate. The first three steps relied on previously pub-
lished work [23] described in Section 1.6. The final step is novel to this method.
The method is evaluated for variability and accuracy of diagnosis using several
datasets.
4.2.1 Region of interest preprocessing
In the first step, regions of interest were extracted from the full CT scan and
prepared for later steps of the algorithm. The input to the algorithm was a pair
of CT scans, I1 and I2, containing the nodule, and seed points located within
the nodule on both scans. Based on this, for each scan, a region of fixed size
was extracted from the original CT scan around each seed point. These regions
were resampled into isotropic space using trilinear interpolation, and these im-
ages, IR1 and IR2 , along with the coordinates of the seed points in the resampled
space were provided to the next stage of the algorithm. The primary reason for
resampling the image was to allow for subvoxel precision for locating and siz-
ing the nodule. However, resampling the image to a higher resolution has the
drawbacks of increasing the image size and computation time. An additional
step of juxtapleural detection was performed to aid in the next step.
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(a) (b)
Figure 4.13: Estimate of nodule location and size for a) scan at T1 and b) scan at
T2. Only the central slice of the region is shown. The location of the nodule is at
the center of the circle; the inner circle indicates the size estimate for the nodule.
4.2.2 Estimation of nodule center and size
Given the resampled regions and seed points, estimates of the nodule center, C1
and C2, and size, S1 and S2, on both regions were determined using the Reeves
et al. algorithm described in Section 1.6, but with one modification – the es-
timation was performed on the resampled isotropic image to achieve superior
location resolution. An example of the result of the algorithm on the central slice
of the nodule on the first and second scans is shown in Figure 4.13. An initial
estimate may, optionally, be provided by the user to the algorithm; this estimate
will be used as an initial condition and the same process described above is used
to determine the nodule size. Note that the computed nodule center and size
from this method are only estimates used to determine the appropriate location
and kernel size for later steps in the algorithm. The region from the second scan
was reduced in size based on the estimated nodule size; the region of the first
scan is not altered in this step.
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(a) (b) (c)
Figure 4.14: Result of region registration, central slice of a) nodule region on first
scan registered to b) second scan and c) difference image between the registered
image and the second scan. Gray indicates no difference.
4.2.3 Nodule region registration
Since the mean weighted density will be computed over regions of interest, the
regions must be comparable from one scan to another. To accomplish this, the
regions were registered – the IR1 image from Section 4.2.1 was registered to the
second scan, IR2 using an intensity-based three-dimensional rigid body regis-
tration algorithm [23]. In brief, the algorithm used a Gaussian-weighted mean-
square-difference matching metric and conducted a search over all parameters
to minimize the metric using Powell’s method. For this method, the initial trans-
lation parameter was derived from the computed difference in nodule centers,
C2 − C1, and the size of the Gaussian weighting function was derived from the
estimated size of the nodule on the second scan (S2). In Figure 4.14, the nodule
on the first scan has been registered to the nodule on the second scan. The regis-
tered image IRR1 is shown on the left with the difference between the registered
image and the nodule on the second scan on the right (IR2 − IRR1). Note that
this step does not alter the resampled image from the second CT scan.
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4.2.4 Density-based growth estimation
Algorithm 1: Density-based growth index measurement
input : Resampled, registered image IRR1 and resampled image IR2
input : Location at T1 C1 and T2 C2
input : Size at T2 S2
input : Days between T1 and T2, ∆T
σ← ωS2
forall the Wi ∈ {IRR1 , IR2} do
forall the w←Wi do
vi ← WeightingFunction(w, x, y, z, xc, yc, zc, σ)
Mi ← M + v
Mi ← Mi/|Wi|
GID ←CalcuateGI(M1, M2,∆T)
Once the two registered images are obtained, the next step is to compute the
growth index for the nodule according to Algorithm 1.
4.2.4.1 Weighting function
The size of the function, σ, is proportional to the size of the nodule on the second
scan (S2) by a constant ω, depending on the weighting function. Two different
weighting functions were tested: a uniform sphere and a 3D Gaussian. The
uniform sphere was centered at (xc, yc, zc) with a radius of σ. The size of the
sphere, σ, was set to the size of the nodule on the second scan (ω = 1) to en-
sure all the majority of the voxels within the nodule are considered. Additional
details about both weighting functions are provided in Section 4.1.
4.2.4.2 Calculate GID
The GID computed using the uniform sphere weighting function, GIUD, was
computed according to the following equation:
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GIUD = 100
[
(M2/M1)30.4375/∆T − 1
]
(4.6)
where M1 and M2 are the estimators measured by density-based growth method
method on the first and second scans, ∆t is the interval in days between scans.
The 3D Gaussian function was introduced in Section 4.1.The Gaussian weight-
ing function was centered at (xc, yc, zc) and the size of the weighting function,
σg, was set to 66% of the estimated nodule radius (ω = 0.66) and truncated at
3σ, so that voxels located further than twice the estimated nodule radius would
not be considered when calculating the mean density (weight of 0). The growth
index from weighted density (GIWD) was computed using Equation 4.5:
GIWD = 100
[(
(a(M2/M1)2 + b(M2/M1) + c
)
30.4375/∆t − 1
]
(4.7)
using the same parameters GIUD, with additional coefficients a = 0.465, b =
0.449, and c = 0.085, as derived in Section 4.1.
4.3 GID evaluation
To evaluate the GID methods, two performance metrics were used: interscan
variability and diagnostic performance. Interscan variability indicates the ex-
pected range of measurements of the same nodule on a different scan, assum-
ing no change in size. In the ideal case, a method would measure no change in
nodule size. Higher variability increases the confidence interval on the growth
measurement, which results in greater uncertainty of the diagnosis. The sec-
ond metric measures how well the growth indices estimated by the GID method
discriminate between benign and malignant nodules.
The GID method was evaluated using both a uniform spherical weighting
function (GIUD) and a 3D Gaussian weighting function (GIWD). Measurements
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Table 4.1: Parameters of datasets
Dataset # nodules Slice Thickness (mm) kVp Current (mA)
Zero-change 20 1.25 - 5.0 120 - 140 40 - 250
Stable 38 1.0, 1.25 120 - 140 80 - 300
Malignant 19 1.0 - 5.0 120 - 140 40 - 300
Complex 4 1.0 - 5.0 120, 140 40 - 300
Table 4.2: Nodule size information
Dataset # nodules Mean, SD Size (mm) Median, range of interval (days)
Zero-change 20 12.69, 3.63 0
Stable 38 6.91, 3.16 393.5, 91 - 1918
Malignant 19 6.68, 3.03 165, 90 - 756
Complex 4 17.61, 3.81 50, 29 - 98
from a volumetric method were computed compared to the GID method to as-
sess correlation.
4.3.1 GID interscan variability
The interscan variablities of the GID and volumetric (GIV) methods were evalu-
ated by measuring the percentage size change (PSC), defined as CUD and CWD
for the GIUD and GIWD methods respectively and by percentage volume change
for the GIV method, on 20 zero-change cases. The interscan variability was de-
fined to be represented as the 95% interval of measurements given by (µ− 1.96σ, µ+ 1.96σ).
Each of the 20 cases had a single nodule imaged on scans several minutes apart
during the preliminary stages of a biopsy. Consequently, the actual volume
change of the nodules between these scans was zero. Ten cases had two scans
of the same slice thickness (1.25 mm), while ten cases had two scans of differ-
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ent slice thicknesses – in seven of these cases, one scan had a slice thickness of
1.25 mm and the other was 2.5 mm, and in three cases, one scan was 1.25 mm
while the other was 5.0 mm. The twenty cases were selected from the Prevent
Cancer Research Foundation database of pulmonary nodules1 according to the
following criteria:
• Solid consistency, as determined by a radiologist
• Successful volumetric segmentation
• Two scans through the entire nodule
The nodules were imaged using either a GE LightSpeed QX/i or LightSpeed
Ultra scanner, and the nodules were all less than 20 mm in size, as measured by
a volumetric measurement method. Additional parameters of the dataset are
provided in Table 4.1 and Table 4.2.
4.3.1.1 Interscan variability results
The results of the interscan variability experiment for the GIUD, GIWD, and the
volumetric method are presented in Table 4.3 for the full dataset (20 nodules)
and the same slice and mixed sliced subsets (10 nodules each). In two cases,
the nodule location and size estimation step failed; for these cases, the methods
were provided a user-estimated radius in addition to the seed point.
4.3.1.2 Interscan variability discussion
The interscan variability experiment measured the variation in size measure-
ment for nodules with no change for different subsets of nodules. For both
1Available from http://www.via.cornell.edu/databases/crpf.html
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Table 4.3: Interscan variability reported as percentage size change (PSC) for GID
method with uniform (GIUD) and 3D Gaussian weighting (GIWD) functions and
a volumetric (GIV) method
Dataset Method Mean PSC (%) SD PSC (%) 95% interval of PSC
Same slice
GIV -3.3 11.2 -25.2, 18.6
GIUD -0.2 6.4 -12.7, 12.4
GIWD 0.6 6.0 -11.0, 12.3
Mixed slice
GIV -21.0 25.6 -71.2, 29.2
GIUD -6.6 9.1 -24.5, 11.2
GIWD -5.0 10.4 -25.3, 15.5
Full
GIV -12.2 21.6 -54.6, 30.3
GIUD -3.4 8.5 -20.1, 13.3
GIWD -2.2 8.9 -19.7, 15.3
methods, the lowest interscan variability was observed on the subset of nod-
ules imaged on scans of the same slice thickness. This is expected, since us-
ing scans of the same slice thickness removes a source of variation (change in
slice thickness). On this subset, the volumetric method had similar interscan
variability to other previously published studies summarized in Section 1.4.4,
which is approximately -20% to 20%, but the GID methods had much lower in-
terscan variability using both weighting functions. These results reinforce the
importance of ensuring that longitudinal scans are taken using the same slice
thickness.
On all the sets of nodules, the GIUD method had much lower interscan vari-
ability than the GIV method. The percentage size change (PSC) measurements
were significantly different between the two methods (p = 0.019, Wilcox signed-
rank test). The largest difference in interscan variability for the GIUD and GIV
methods was on the subset of nodules imaged on scans of different slice thick-
nesses where the GIUD method had nearly 3 times less variability than the GIV
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method. The decreased variability suggests that the GIUD method will allow for
less uncertainty in the growth index measurement.
The interscan variability for the GIWD was similar to the GIUD method; the
PSC measurements did not differ significantly (p = 0.294, Wilcox signed-rank
test) between the GIWD and GIUD methods on this dataset. The similarity be-
tween the GIWD and GIUD methods was not surprising – since these are zero-
change nodules, the ROIs should remain the same from one scan to the other
and we would expect the GIWD and GIUD methods to give similar results. The
variability was slightly lower on the same slice thickness subset of nodules com-
pared to the mixed slice thickness subset. This may be due to the additional
variation in the ROI appearance in the mixed slice thickness subset.
One of the assumptions of the GID method is that a nodule will have an
approximately spherical shape. If a nodule deviates significantly from a sphere,
such as a lengthy, flat nodule, the ROI will include either include a substantial
number of non-nodule voxels or exclude a number of nodule voxels, thereby
altering the apparent size of the nodule. However, in this dataset, all the nodules
were approximately spherical.
Despite these limitations, on the datasets evaluated in this study, the GID
methods provided more consistent measurements than the volumetric method.
However, for a nodule growth measurement to be effective, it must not only be
consistent, but it must also be sensitive to growth. The next section evaluates
the performance of the method for measuring nodule growth.
4.3.2 GID Diagnostic performance
The motivation for measuring pulmonary nodule growth index is to diagnose
malignant nodules. This experiment evaluated how well the growth rates from
120
the GID and volumetric methods (GIV) predicted malignancy by using datasets
of benign and malignant nodules to establish a growth rate threshold for malig-
nancy. There were two steps to the evaluation:
1. Use the benign dataset to establish a threshold on the growth index, above
which nodules would be considered malignant
2. Apply this threshold to the malignant dataset to measure the diagnostic
performance
To establish the growth index threshold, the upper value of the 95% interval of
the growth indices of the benign nodules were computed. The upper 95% value,
T, was computed using the following equation:
T = µ+ 1.96 · σ
where µ is the mean growth index for the benign nodules and σ is the stan-
dard deviation of the benign nodules growth indices. This threshold was used
to classify nodules from both the the malignant and benign datasets, and the
accuracy was reported for each dataset.
Another method to evaluate the diagnostic performance is to produce a re-
ceiver operating characteristic (ROC) curve, which plots the sensitivity (num-
ber of malignant nodules correctly classified) against 1-specificity (number of
benign nodules correctly classified) for varying thresholds.
The benign nodules were confirmed by either biopsy or the absence of clin-
ical change in a two year time period, while the malignant nodules were con-
firmed by biopsy or resection. All nodules were selected from the Weill Cornell
Medical College database according to the same criteria described in Section
4.3.1. There were 38 benign nodules, and all of the nodules but one had scans of
the same slice thickness. Scans were acquired with either a GE LightSpeed Ultra,
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LightSpeed Pro 16, LightSpeed VCT, HighSpeed CT/i, or Genesis scanner. The
dataset had 19 malignant nodules, which were selected to have an interval of at
least 90 days and a volume change of at least 30%, as measured by the volumet-
ric method described in Section 1.6. These criteria were selected to ensure that
the volume change was greater than the measurement uncertainty measured by
previous studies. An additional four malignant nodules with a complex appear-
ance were included with scans taken at intervals ranging from 29 to 98 days, for
a total of 23 malignant nodules. The scans for the malignant nodules were ac-
quired using the following GE scanners: LightSpeed Ultra, LightSpeed QX/i,
HighSpeed CT/i, and Genesis. Additional parameters for both the malignant
and benign nodules are provided in Table 4.1 and Table 4.2.
For the volumetric method, the growth index was computed using the vol-
ume instead of the density:
GIV = 100
[
(V2/V1)30.4375/∆T − 1
]
where V1 and V2 are the volumes computed by the volumetric method on the
first and second scans and ∆T is the interval in days between scans.
4.3.2.1 Diagnostic performance results
The diagnostic performance was determined by applying a threshold to the
growth index for each nodule, and determining whether the nodule was clas-
sified correctly. The GI range for the benign and malignant datasets are shown
in Table 4.4. Using the thresholds given in Table 4.5 computed from the benign
nodule dataset, the GID and volumetric methods classified the nodules accord-
ing to their GI. The diagnostic performance for the GID and volumetric methods
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Table 4.4: Growth index statistics for both methods on the stable and malignant
datasets
Dataset Method GI Range Median GI
Benign
GIV -6.2 – 6.4 0.10
GIUD -2.9 – 1.4 0.043
GIWD -3.3 – 1.7 0.17
Malignant
GIV 3.0 – 45.5 16.7
GIUD 1.7 – 12.6 5.8
GIWD 1.9 – 18.1 6.9
Table 4.5: Malignancy thresholds determined from stable nodules.
Method Mean GI SD GI Threshold for malignancy (%/month)
GIV 0.07 2.45 4.87
GIUD -0.07 0.83 1.56
GIWD -0.03 1.00 1.92
are provided in Table 4.6. The GI malignancy threshold was set from the upper
limit of the 95% interval for the benign nodules. Note that the performance for
the benign nodules is optimistic, since these nodules were used to establish the
threshold.
The ROC curve is shown in Figure 4.15 for the classification performance
for the GID and volumetric methods for the entire dataset of benign and malig-
Table 4.6: Nodules correctly classified based on GI for GIUD, GIWD, and GIV
methods
Method Benign Malignant
GIV 92.1% (35/38) 73.9% (17/23)
GIUD 100% (38/38) 95.7% (22/23)
GIWD 100% (38/38) 95.7% (22/23)
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nant nodules. The volumetric method failed to segment four nodules, so for the
purpose of making the ROC curve, the GI values for these nodules was set as
0%/month. The area under the ROC curve (AUC) was 1.00 for GIUD , 0.997 for
GIWD, and 0.897 for GIV. The AUC for GIUD was higher than for GIWD, despite
both methods having identical performance in 4.6; this was due to the method
by which the classification threshold was selected. The lowest malignant GIUD
was 1.54 %/month, while the highest benign GIUD was 1.39 %/month and thus,
no confusion between the malignant and benign nodules.
For these nodules, the differences in growth index values for the benign nod-
ules were not statistically significant (p = 1.00, Wilcox signed-rank test for GIUD
and GIV , p = 0.84 for the GIWD and volumetric methods) between the GID and
volumetric methods, but the growth indexes for the malignant nodules were
statistically significantly different (p < 0.01, Wilcox signed-rank test). The dif-
ferences in GI for the benign nodules between the GIUD and GIWD methods
were not significantly different (p = 0.71), but there was a significant difference
(p < 0.01) for the malignant nodules. The GIWD method incorrectly classified
one of the 19 malignant nodules, but correctly classified all four of the complex
malignant nodules, while the GIUD method correctly classified all 19 malignant
nodules, but only half (2/4) of the complex malignant nodules.
The GIUD values were plotted against the GIV values for the benign and
malignant nodules in Figures 4.16 and 4.17. For the plot of GIUD versus GIV, the
parameters of the best fit line, y = a · x+ b, were a = 0.318 and b = 0.151, with a
coefficient of determination r2 = 0.905, while for the GIWD, the coefficients were
a = 0.280 and b = 0.142, with a coefficient of determination r2 = 0.880.
Finally, the GIWD values were plotted against the GIUD values in Figure 4.18.
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Figure 4.15: ROC curves showing diagnostic performance for GIWD, GIUD, and
GIV
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Figure 4.16: Plot of GIUD versus the GIV indicating a linear relationship
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Figure 4.17: Plot of GIWD versus GIV values indicating a linear relationship with
a similar appearance to 4.16
The parameters of the best fit line were a = 0.884, b = 0.002, and r2 = 0.981.
4.3.2.2 Diagnostic performance discussion
The main purpose for measuring pulmonary nodule growth index is to aid in
establishing the malignancy status of a suspicious nodule. The diagnostic per-
formance of the GID method, with either the uniform weighting or 3D Gaussian
weighting, was significantly better than the volumetric method, especially for
the malignant nodules. Compared to the volumetric method, five additional
malignant nodules were correctly classified by GIWD, and four malignant nod-
ules by the GIUD method. Three additional benign nodules were correctly classi-
fied by both density methods. This improvement in performance was especially
impressive considering the density methods were much simpler than the volu-
metric method. All four complex malignant failed to be segmented correctly by
the volumetric method, which led to lower performance on the malignant nod-
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Figure 4.18: Plot of GIWD versus GIUD values that show a close relationship
between the two methods, as indicated by the linear relationship with a slope
near 1
ules than the density methods. Two of the four complex nodules (50%) were
correctly classified by the GIUD method, while all four were correctly classified
by the GIWD method; a central slice of these nodules is shown in Figure 4.19.
All the methods had GI thresholds that were consistent with stability accord-
ing to other studies [39], which consider nodules with a GI less than 5.4%/month
to be benign, though the GIUD method had a much lower threshold. The GIUD
method had much smaller ranges for the GI, compared to the volumetric method,
for both the malignant and benign nodules, and the median GI for the malig-
nant nodules was closer to zero for the GIUD method. This might suggest that
the GIUD and volumetric methods are not well correlated. Plotting the GIUD re-
sults against the GIV results showed a linear relationship, but the best fit linear
model differed from the identity line, which indicates some differences in the
measurements between the two methods. This is likely attributable to the fact
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(a) (b)
(c) (d)
Figure 4.19: Central slice of three nodules which were not successfully seg-
mented by the volumetric method. All these nodules are malignant. Images
are not to scale.
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that the GIUD method includes all voxels belonging to any soft tissue in calculat-
ing the nodule size, while the GIV method only includes voxels that it considers
to be part of the nodule. To address this problem, the next section introduces a
weighting function that was modified to decrease the weight of structures fur-
ther from the nodule center.
The GIWD method was developed to address nodules with a complex ap-
pearance where the boundary between the nodule and lung parenchyma is un-
certain, and for these cases, there was a substantial benefit to the GIWD method
over the GIUD method. The GIWD method correctly classified all the complex
malignant nodules, while the GIUD method only correctly classified half of the
nodules. This was responsible for a slight improvement in the AUC, from 0.95
for the GIUD method to 0.99 for the GIWD method. However, despite correctly
classifying more of the complex nodules, this performance came at the expense
of correct classification on the easier malignant nodules, where the GIWD mis-
classified a nodule. A montage of slices through the nodule is shown in Figure
4.20. This nodule, the slowest growing malignant nodule in the dataset, has
a simple appearance, except for the attachment to the pleural surface. Since
the size of the nodule was estimated well, the GIUD method was able to avoid
considering voxels in the pleural surface in its density calculation. In contrast,
the GIWD method would have considered some of the voxels in the pleural
surface in its density measurement, possibly a substantial amount relative to
the size of the nodule on the first scan, thereby reducing the apparent growth.
The GIWD for this nodule was 1.32%/month, which is considerably lower than
the threshold of 1.92%/month for malignancy. The GIUD for the nodule was
1.65%/month, which was slightly higher, but not drastically different. The
GIWD method still classified more malignant nodules correctly than the volu-
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(a) (b)
Figure 4.20: Several slices through the malignant nodule misclassified by the
GIWD method at a) Time 1 and b) Time 2. The interval between the scans was
756 days.
metric method which only correctly classified 89.5% of the malignant nodules.
The GIWD and GIUD values for the benign nodules were much smaller than
the GIV values. The GIWD method had larger ranges of values than the GIUD
method, which is probably due to additional voxels which were included by the
GIWD method that were not part of the nodule, even though they were likely
assigned a small weight. The differences in the GI values for the malignant
nodules between the GIWD and GIUD methods were statistically significant, but
not the differences in GI for the benign nodules.
The relationship between the GIWD and GIUD measurements were nearly
linear, with a high coefficient of determination. The intercept of the best fit line
was 0, indicating that the GIWD was not biased against the GIUD method, but
the slope differed slightly from 1, which reinforces the fact that there are differ-
ences between the methods. In comparing the GIWD method to the volumetric
method, there was slightly less correlation between the GIWD and volumetric
methods (r2 = 0.880) than the GIUD and volumetric methods (r2 = 0.905),
though given the size of the datasets used in the experiment, the differences
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are likely not significant.
The GIWD method has many of the same limitations as described for the
GIUD method, but unique to the GIWD method is the choice of the 3D Gaus-
sian weighting function. For some nodules with very abrupt transitions from
the nodule to the lung parenchyma and surrounding structures, applying the
weighting function reduces sensitivity by including non-nodule voxels from
other nearby structures, whereas the GIUD method, which has a sharp cutoff at
the nodule boundary, would only consider voxels belonging to the nodule. Dif-
ferent weighting functions, such as those with a much more abrupt transition
region, may improve the performance of the GIWD method without compromis-
ing its sensitivity.
4.4 Density-based growth measurement summary
The concept of measuring pulmonary nodule growth from the density change
in a region is an alternative to the current and only approach of volume mea-
surement. This density approach removes the need for explicit segmentation,
which is a problem of the volumetric approach for complex nodules. The suc-
cess of both the GIUD and GIWD methods for diagnosing pulmonary nodules is
very promising compared to volumetric segmentation-based techniques. The
GIUD method, which uses a uniform weight for all voxels in the region of inter-
est, performed very well, despite the presence of other soft tissue structures in
the ROI. The GIWD method, which applies a Gaussian weight to the ROI, classi-
fied one additional complex nodules correct compared to the GIUD method, but
there were nodules that could not be correctly distinguished using the growth
index values provided by the GIWD method.
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CHAPTER 5
PILOT STUDY TO MEASURE PULMONARY NODULE GROWTH RATE
IN MOUSE MODELS IMAGED WITH MICRO-CT
To aid in the quantitative evaluation of disease progression and treatment
response in mouse models, a pilot study was performed to determine the fea-
sibility of evaluating pulmonary nodule growth from micro-CT scans with an
automated method. Mouse models, mice which are modified to be predisposed
to developing cancer, are often used in early stage cancer research, due to their
small size, ease of breeding, physiological and molecular similarities to humans,
and entirely sequenced genome [69]. With the introduction of non-invasive
imaging modalities, such as micro-CT, both disease progression and treatment
response can be monitored in longitudinal studies, where the same animal is
analyzed over a period of time. Current methods of measurement from these
imaging modalities are crude and require extensive manual intervention. Not
only does this require more time and effort from researchers, but it also intro-
duces variation into the measurement; these are the same issues that automated
algorithms for measurement of nodules in human lung cancer patients are de-
signed to mitigate.
In this pilot study, the automated volumetric segmentation method described
in Section 1.6 was adapted to measuring pulmonary nodules in mice imaged on
micro-CT. The method was modified to address both the difference in scale be-
tween the human and mouse nodules as well as differences in the quality of the
micro-CT scan. Mice are roughly 10 times smaller than humans, with a human
CT scan covering approximately 30 cm compared to about 3 cm for a micro-CT
scan. The micro-CT scan has additional noise and, for the particular scanner
used in this study, a lack of calibration. Six nodules in four lung nodule-bearing
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mice were sequentially scanned over a span of several months and their vol-
umes measured by both the automated method and manual uni-dimensional
measurement. Rather than use the manual measurements as the ground truth,
we assumed the growth of the nodules followed the exponential model and
evaluated the methods based on their fit to the model. We hypothesized that
the growth rate measured by the automated algorithm would better match the
exponential model than manual measurements.
5.1 Pulmonary nodules in mouse models imaged with micro-
CT
Pulmonary nodules in mouse models have a similar opaque appearance on
micro-CT as nodules in a human scan. Examples of a a central slice through a
murine and human pulmonary nodule on CT are shown in Figure 5.1. As with
a human CT scan, the micro-CT scanner has a rotating X-ray source, and the
value of a voxel in the scan is proportional to the radiodensity at that location.
The resulting 3D image is visualized as a series of slices. While the underlying
principles are the same in micro-CT scanners, there are several differences that
arise from the much smaller scale in micro-CT.
5.1.1 Differences between murine micro-CT and human CT
The micro-CT scans in this study have a resolution of 50 µm × 50 µm × 50 µm
compared to a typical resolution of 0.6 mm × 0.6 mm × 1.0 mm for human CT
scans. The images in Figure 5.1 show a marked increase in image noise in the
micro-CT scan compared to the human CT scan and a decrease in the contrast
between the parenchyma and soft tissue. In addition to these differences, there
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(a) (b)
Figure 5.1: A central slice through a nodule on a) a micro-CT scan of a mouse
and b) a CT scan of a human patient. Note that the images are not to the same
scale.
are also challenges in obtaining scans of a live mouse with the micro-CT scanner
which are not a problem with modern CT scanners.
The resolution in an X-ray-based scanner is dependent on the focal spot size
of the X-ray source and several parameters of the X-ray detector, including pixel
size, dynamic range, and noise characteristics [70]. In order to image at the small
resolutions required in micro-CT, X-ray sources with small focal spots are re-
quired; removing heat from these sources limits the speed of imaging. For X-ray
detectors, the intensity of the signal depends on the quantity of X-ray photons
that reach the detector; all other things being equal, a detector with a smaller
physical pixel size receives less photons than a detector with a larger physical
pixel size, reducing the signal to noise ratio [71]. Both of these characteristics
result in a micro-CT scanner with a slower scanning speed and lower signal to
noise ratio than a comparable human CT scanner. The longer scan times do not
allow for a complete acquisition of all projections around the animal in a single
breath. If this is not considered during acquisition, each projection will be ac-
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quired at a different stage of the respiratory cycle, resulting in artifacts in the CT
image. To address this, respiratory gating, where each projection is acquired in
the same part of the animal’s respiratory cycle, is required.
5.1.1.1 Lack of contrast between lung parenchyma and soft tissue
The micro-CT scans have lower contrast between the lung parenchyma and soft
tissue than in human CT scans. This is attributable to the amount of soft tissue
in the lung parenchyma—the lung parenchyma is comprised primarily of the
alveoli, which in a human, have a much larger mean linear intercept (MLI) of
210 µm compared to a mouse, 80 µm [72]. The MLI is a measure of the mean free
distance between air spaces in the lung and is often used as an estimator of the
alveolar diameter. The blood-gas barrier thickness in a human is 0.62 µm, com-
pared to 0.32 µm for a mouse—these measurements suggest that a larger per-
centage of the lung parenchyma is tissue in a mouse lung compared to a human
lung. Given the resolution of the micro-CT scan and the size of the alveoli, the
lung parenchyma has a much higher radiodensity than the lung parenchyma
in a human CT scan, which in turn reduces the contrast ratio between the lung
parenchyma and other structures in the lungs. A comparison of histograms for
the radiodensity of lung parenchyma and soft tissue for a human CT scan and
murine micro-CT scan is shown in Figure 5.2. The histograms were generated
by sampling ten manually selected 7x7x3 pixel regions in the lung parenchyma
and six regions in various areas of soft tissue. The separate and narrow distri-
butions of radiodensity for the lung parenchyma and soft tissue in the human
CT scan allows for a fixed threshold to segment the two tissue types in the CT
scan—due to the large separation, slight variances from scan to scan will not
have a significant effect on the resulting segmentation. On the other hand, in the
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(a) (b)
Figure 5.2: Comparison of the histograms of the radiodensity of lung
parenchyma and soft tissue for a) a human CT scan and b) a murine micro-
CT scan. Note the clear separation between the two tissue types in the human
CT scan, while there is overlap in the murine scan.
micro-CT scan, the distributions of the lung parenchyma and soft tissue over-
lap. Not only does this overlap prevent a threshold from clearly segmenting the
two tissue types, but the threshold has a significant effect on the segmentation
of the two types.
5.1.1.2 Inconsistent scanner calibration
Care is taken to ensure that CT scanners used in clinical situations are properly
calibrated; as a result, the intensity of a voxel of air can be expected to be -1000
HU and a voxel of water to be 0 HU. The micro-CT scanner used for the scans
in this study was not well-calibrated; this is illustrated by the the histograms of
the intensities of phantoms in Figure 5.4. There was a phantom, shown in Fig-
ure 5.3, with an equivalent density as air (-1000 HU), a water-equivalent phan-
tom (0 HU), and a bone-equivalent phantom. The exact radiodensity of the bone
136
Figure 5.3: Phantom with material densities similar to water, air, and bone
phantom was unknown, but it should be the same in all scans. Note that the in-
tensities in Figure 5.4a are shifted slightly lower than the intensities in Figure
5.4b, but the shift is not simply additive. The mean of the air, water, and bone
intensity distributions are 4.2 HU, 25.7 HU, and 20.6 HU lower respectively in
Figure 5.4b than in Figure 5.4a. In the ideal case, there should be no shift in the
mean intensities of the phantoms between scans.
5.1.1.3 Live mouse imaging with micro-CT
Imaging a live mouse with a micro-CT scanner poses a challenge due to the lack
of speed of the scanner and uncooperativeness of the mouse. These are both
addressed by anesthetizing the mouse during the scan, which kept the mouse
still and steadily breathing during the scan. The micro-CT scanner used in this
study, a GE eXplore CT 120 micro-CT scanner, had limitations in the frequency
of X-ray tube activations and the data processing speed. Configuring the scan-
ner to produce a scan as fast as possible resulted in a scan time of multiple
minutes for the field of view that included the entire mouse at the desired res-
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(a) (b)
Figure 5.4: Histograms of intensities of phantoms of known radiodensity for
two different scans. The materials, from left to right on the histograms, were
air (-1000 HU), water (0 HU), and bone. In scan a), the mean intensities were
-927.6 HU, 92.2 HU, and 2612.6 HU respectively, compared to scan b) with mean
intensities of -931.8 HU, 66.5 HU, and 2592.0 HU respectively.
olution. Performing a scan in this configuration would have been unacceptable
due to the respiratory motion of the mouse—the motion would cause blurring
in the image.
To address this problem, respiratory gating was used during the scans. In
respiratory gating, the scanner is configured to only obtain image projections
when the mouse is at the rest period in its respiratory cycle. Ideally, this would
place the mouse lung in the same position and size for every projection. A view
is a single position of the X-ray source around the gantry, and in this study,
a scan had 720 projections, with 2 frames taken at each view to enable frame
averaging.
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5.1.2 Previous methods of pulmonary nodule measurement in
mouse models
Most previous methods of pulmonary nodule measurement have been based
on simple techniques, such as thresholding and region growing, with extensive
manual intervention. Early approaches, such as Haines et al., did not attempt
to specifically segment the pulmonary nodules; the soft tissue was segmented
from the lung parenchyma using thresholds, region growing, and manual con-
touring, and the change in soft tissue volume was used as a measure of tumor
burden [73]. Fushiki et al. used a similar method with additional manual and
semi-automated segmentation to select only the tumors [74]. A more advanced
method applied a semi-automated tool which presented a preliminary auto-
mated tumor boundary. However, manual modification of the boundary was
required to produce an acceptable segmentation [75]. All of these methods re-
quire extensive user interaction with the system, which is time-consuming and
may result in inconsistent measurements among users.
5.2 Pulmonary nodule growth rate algorithm modifications to
support murine nodule measurement
The segmentation algorithm described in Chapter 1 was designed to segment
pulmonary nodules from CT scans of human patients. As described in the previ-
ous section, there are many differences between a human CT scan and a murine
micro-CT scan, requiring changes to the algorithm to accommodate these dif-
ferences. The three main focus areas were the change in resolution, additional
scanner noise, and reduced contrast in the micro-CT scans.
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(a) (b)
Figure 5.5: The median filter, applied to the a) original image, reduces the visible
noise in the b) output image
5.2.1 Pre-filtering and modified resampling to accommodate res-
olution change and noise
The noise in the micro-CT scan had a high enough intensity to interfere with the
segmentation algorithm, primarily along the boundary between the nodule and
lung parenchyma. This would manifest as either over- or under-segmentation
of the nodule. To reduce this noise, a median filter was applied to the region of
interest extracted from the micro-CT scan to remove the noise while maintain-
ing the edges along the nodule. Based on empirical observations, a 2D median
filter with a 3 x 3 pixel window was selected. Larger windows, as well as 3D
windows, were tested, but did not have any visual improvement over the se-
lected window size. The effect of the filter is illustrated in Figure 5.5, which
shows a reduction in image noise in the output image.
After the noise-reducing filter, the region of interested was resampled. In
the original segmentation algorithm, the CT scan was resampled into 0.25 mm
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isotropic space from a resolution of approximately 0.625 mm x 0.625 mm x 1.25
mm. For the micro-CT scans, which are imaged at an isotropic resolution of 50
µm, the images were resampled into an isotropic voxel space of 25 µm. The
higher resolution provides for more precise boundaries along curves [22].
5.2.2 Adaptive thresholding for low contrast
The next step in the segmentation algorithm was to threshold the resampled re-
gion of interest to separate the soft tissue from the lung parenchyma. While the
use of an adaptive threshold does not provide much benefit for segmenting nod-
ules from human CT scans compared to a fixed threshold [23], murine micro-CT
scans exhibit significant variation of the radiodensity of the lung parenchyma
and soft tissue from one scan to another. The histograms of the radiodensity
distributions of lung parenchyma and soft tissue are shown for two scans taken
at two different times of the same mouse in Figure 5.6. Note that there is a
bi-modal distribution, which indicates that we can separate the majority of the
two tissue types with a threshold, but despite being the same mouse, these scans
show a clear shift in the mean of both distributions. Using the same threshold
for both scans would result in either over- or under-segmentation of the nod-
ule. To compensate for this variation, an adaptive threshold was selected for
each scan based on these histograms.
The histograms were generated by sampling ten manually selected 7x7x3
pixel regions in the lung parenchyma and six regions in various areas of soft
tissue of the original micro-CT scans, prior to resampling or region of interest
selection. The threshold was manually selected to be the midpoint of the two
peaks, as shown by the plots in Figure 5.6 and provided as an input to the algo-
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(a) (b)
Figure 5.6: Radiodensity distributions of the soft tissue and lung parenchyma
in two different scans of the same mouse
rithm.
5.3 Exponential growth rate validation study
The goal of this study was to show that automated growth analysis was viable
for micro-CT scans. However, verifying the correctness of the algorithm is diffi-
cult, due to many of the same factors described for human CT scans in Section
1.4. In brief, manual measurements are unreliable—the high inter- and intra-
reader variability makes manual measurements unsuitable for ground truth.
While we could have performed zero-change “coffee break”-type studies us-
ing mice, these studies have a significant limitation—measuring nodules with
zero-change only provides information on how the algorithm performs in zero-
change situations. To evaluate the algorithm for nodules with growth, we as-
sumed the growth of nodules would follow the exponential growth model. If
the nodules grow exponentially, the growth measured by the algorithm should
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also show an exponential growth rate.
In this study, the growth rates of nodules in four mice were followed from
the first appearance of the nodule in the scan until the mice began to show se-
vere symptoms of disease. These growth rate measurements were computed
by the automated algorithm described in Section 5.2 and by a manual measure-
ment. Both sets of measurements were compared to the exponential growth
model.
5.3.1 Murine dataset
This study used a novel mouse lung tumor model over-expressing the small
subunit of the enzyme ribonucleotide reductase (RNR) combined with inactiva-
tion of the DNA repair gene Msh6; this model results in 100% of mice develop-
ing pulmonary nodules by six months of age [76]. These nodules histopatho-
logically resemble human papillary adenocarcinomas, the most common form
of human non-small cell lung cancer. All mice were maintained identically, fol-
lowing guidelines approved by the Cornell University Institutional Laboratory
Animal Use and Care Committee. After the last micro-CT scans, the mice were
euthanized by asphyxiation with carbon dioxide.
Nodules were selected that were present on at least three scans, were largely
solid in appearance, and were only attached to the chest wall at a single point
(the automated algorithm was only designed to handle a single attachment to
a chest wall). Six nodules from four mice fulfilled these criteria and were fol-
lowed in this study. Information about the mice is provided in Table 5.1. Each
mouse was scanned a minimum of four times, with at least three weeks time
interval in between. At least one tumor was visible for each mouse in all scans
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# of nodules Age at initial scan (months) Age at final scan (months)
1 1 11 14
2 1 12 15
3 2 12 17
4 2 11 15
Table 5.1: Information on mice in the study
at different time points. Nodules were identified on the each scan and followed
in subsequent scans. The volume of each nodule at corresponding time point
was computed by the automated algorithm and recorded for growth analysis.
Two observers independently verified the segmentation of the nodules by the
algorithm. At the end of the last live scan, mice were euthanized. Necropsy
and histological analyses were performed to validate the nodules identified in
micro-CT scans.
5.3.2 Scanning protocol
The protocol for scanning mice is complicated by the duration of a single scan,
which was about 30–45 minutes, depending upon the breathing rate of the
mouse. Prior to the scan acquisition process, the mice were anesthetized in an
induction chamber with a continuous flow of 4% isoflurane/oxygen mixture.
After the rate of breathing of the mice slowed, the isoflurane/oxygen mixture
was reduced to 1-3% and maintained at this range during the duration of the
micro-CT scan [77]. Scans of the chest region were acquired using a GE eXplore
CT 120 micro-CT scanner with a tube current of 50 mA and a voltage of 100
kV. Each scan consisted of 720 projections in a single full rotation of the gantry.
Two frames were acquired at each position of the gantry and averaged together
prior to being transferred to the workstation for reconstruction; scans were re-
constructed at 50 x 50 x 50 µm3 voxel dimensions. Respiratory gating of the mice
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was achieved using the BioVet physiological monitoring and triggering system
(m2m Imaging Corp.). The final image volume varied according to the selected
region of interest, but typically ranged from 400 x 400 x 500 slices to 800 x 550 x
1000 slices. Scans were converted from the manufacturer’s proprietary format
to DICOM and then imported into research software.
The scan parameters selected for this study were determined through em-
pirical testing. Although previous studies have imaged mice using micro-CT,
the scanner used in this study was newly released at the time of the study, so
we needed to optimize the tradeoffs between speed, image quality, and radia-
tion dosage of this particular scanner. The acceptable radiation exposure to the
mouse and the scan time were the primary constraints that limited the quality
of the scans. A single live mouse was scanned six times with different scan-
ner parameters; the majority of these scans were performed with a low number
of views per scan with no frame averaging, which substantially reduced the
scan time to approximately 10 minutes. The time required for a scan directly
increases with the number of views per scan and the number of frames used for
averaging. The noise associated with each set of scanner parameters was quan-
tified by measuring the standard deviations of the lung parenchyma radioden-
sity distributions, which were computed using the same approach described in
Section 5.2.2, but with only five local regions. A table of the tested parameters
and the resulting noise is provided in Table 5.2. The scan with the lowest noise
was produced with the following parameters: 100 kVp, 50 mA, 20 ms exposure
time, 360 projections, and 2 frame averaging. To increase the visible details, the
parameters used in the following live imaging were 100 kVp, 50 mA, 20 ms ex-
posure time, 720 projections and 2 frame averaging with 50μm reconstruction
resolution. All live scans were acquired using these optimized parameters with
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Table 5.2: Scan parameters and the associated noise measurements estimated
using the standard deviation (SD) of the lung parenchyma radiodensity distri-
bution
Current (mA) Voltage (kVp) Exp. time (ms) # proj. Frame avg. SD (HU)
1 32 70 32 220 1 53.3
2 50 70 32 220 1 80.4
3 32 80 32 220 1 45.6
4 50 80 32 220 1 41.1
5 50 100 32 220 1 39.2
6 50 100 20 360 2 30.5
Table 5.3: Micro-CT scanner parameters used in this study
Current (mA) Voltage (kVp) Exp. time (ms) # proj. Frame avg.
All, except: 50 100 20 720 2
Mouse 1, T 3 50 100 20 720 1
Mouse 2, T 1 50 100 20 440 2
the exception of two scans shown in Table 5.3.
5.3.3 Growth rate evaluation
In this study, each mouse was scanned several times. The nodule growth rate
can be computed from the nodule volume on each scan and time interval be-
tween scans. The exponential growth model is described in Section 1.3; some of
the equations will be repeated here to provide context for the analysis.
The exponential growth model is defined for a pair of volume measurements
as:
V2 = V1 · eλ·∆t (5.1)
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where V2 is the volume of the nodule at time t2, V1 is the volume of the nodule
at time t1, and ∆t is the time interval t2 − t1 in days. Since we have more than
two scans, we fit all of the measurements for a nodule to a single exponential
model. This was performed using non-linear least squares regression in the R
statistical package [68], which provides estimates of the parameters V1 and λ.
The goodness of fit of the model was quantified using the residual standard
error (RSE); a perfect fit to the model would have an RSE of 0.
For a pair of scans, we typically use the growth index (GI) to report the
growth rate:
GI = 100 ·
[
(V2/V1)
30.4375/∆t − 1
]
(5.2)
We can also report a GI for a particular value of λ by rearranging Equation 5.1
in terms of the exponential coefficient λ:
λ =
ln
(
V2
V1
)
∆t
=
ln V2 − ln V1
t2 − t1 (5.3)
which, after substitution into Equation 5.2, results in an expression in terms of
λ:
GImodel = 100 ·
[
e30.4375λ − 1
]
(5.4)
If the nodule growth follows the exponential model, as we hypothesize, the
RSE will be low.
5.3.4 Comparison with manual measurements
The growth measured by the automated algorithm was compared to the growth
manually measured by an observer—the author. The author measured each
tumor by selecting the axial slice through the tumor with the largest cross-
sectional area and marking the largest diameter. This diameter was converted
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to a volume measurement, assuming a uniform spherical model; this closely
mirrors the measurement method used in RECIST [9]. The growth rates from
the manual measurements were evaluated as described in the previous section
and compared to the automated measurements.
5.4 Exponential growth rate validation results
In this study, we monitored the progression of six pulmonary nodules present-
ing in four mice using micro-CT. The growth of each nodule over time, com-
puted by the automated method, is illustrated in Figure 5.7. In this graph, the
volume of the nodule is plotted over the time from the initial scan. The data
were fit to an exponential growth model, and this model was used to estimate
the growth index (GI) of the nodules, which are provided in Table 5.4. The ini-
tial nodule volume varied from 0.050 mm3 to 0.898 mm3. Nodules with smaller
initial volumes tended to grow slightly faster, with the exception of the nodule
in mouse 2. The GI values of the nodules ranged from 20.04–81.04% per month.
Information on the model fits is provided in Table 5.6; the nodules with the low-
est residual standard error (RSE) were 3B and 4A, if nodule 1, which only had
three measurements, is discounted. These also appear to have the closest fit to
the exponential model in the plot in Figure 5.7.
The manual growth measurements are plotted in Figure 5.8 and provided in
Table 5.5; the GI values ranged from 24.12–205.58% per month. The initial vol-
umes from the manual measurements were always larger than the automated
measurements, with the exception of nodule 4B. This may have been due to the
longest dimension of the nodule lying along the axial dimension of the scan. The
growth rates were also larger for the manual measurements in three of the six
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Figure 5.7: Plot of automated measurements over time for all nodules in the
study
Table 5.4: Growth indices (GI) of six nodules detected in this study computed
from automated volume measurements
Mouse (nodule) Initial volume (mm3) Automated GI (%/month)
1 0.685 20.04
2 0.898 74.01
3 (A) 0.324 48.99
3 (B) 0.052 43.65
4 (A) 0.190 80.49
4 (B) 0.050 81.04
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Table 5.5: Growth indices (GI) of six nodules detected in this study computed
from manual volume measurements
Mouse (nodule) Manual Initial Volume (mm3) Manual GI (%/month)
1 0.882 205.58
2 0.776 146.19
3 (A) 0.556 33.94
3 (B) 0.195 24.12
4 (A) 0.641 488.37
4 (B) 0.022 55.95
nodules, often by a significant amount. In the other three nodules, the growth
rate was only slightly below the growth rate computed from the automated
measurements. The fit of the data to the exponential model, provided in Ta-
ble 5.7, was generally worse (higher RSE) for the manual measurements than
the automated measurements with the exception of nodule 2, where the man-
ual measurement of the volume on the last scan of nodule 2 showed a greater
increase over the second to last scan than the automated measurement did.
The growth rate computed from the manual measurements for nodule 4A had
a large difference from the automated growth rate measurement and a much
higher RSE.
5.5 Discussion
The hypotheses made for to this study were that the measured growth rate of
murine pulmonary nodules was exponential and that the automated method
would perform better than manual measurements, with measurements closer
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Figure 5.8: Plot of manual measurements over time for all nodules in the study
Table 5.6: Model fits for automated measurements (RSE = Residual standard
error)
Mouse (Nodule) # scans Auto V0 Auto λ Auto RSE
1 3 0.6534 0.0060 0.0599
2 4 0.63854 0.0182 0.2850
3 (A) 6 0.2141 0.0131 0.1736
3 (B) 6 0.0466 0.0119 0.0044
4 (A) 6 0.1060 0.0194 0.0827
4 (B) 6 0.1310 0.0195 0.2067
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Table 5.7: Model fits for manual measurements
Mouse (Nodule) # scans Manual V0 Manual λ Manual RSE
1 3 0.7541 0.0367 0.1659
2 4 0.9400 0.0296 0.1741
3 (A) 6 0.7918 0.0096 0.5851
3 (B) 6 0.2351 0.0071 0.0560
4 (A) 6 0.0050 0.0583 0.7166
4 (B) 6 0.3784 0.0146 0.3959
to the exponential model. The growth rates computed from both the automated
and manual measurements show a trend towards exponential growth, as shown
by the plots in Figures 5.7 and 5.8, and the growth measured by the automated
method had better agreement with the exponential growth model, evidenced
by the lower residual standard errors (RSE), than the manual method on five
of the six nodules. Assuming the actual growth of the nodules followed the
exponential model, this suggests that the automated measurements are more
accurate.
The automated method measured smaller volumes than the manual method
in all cases; this was due to the uni-dimensional manual measurement on the
slice where the nodule appeared largest. The volume for the manual method
was computed assuming a spherical model with a radius equal to half the uni-
dimensional measurement, which would result in a sphere that totally encloses
the nodule, unless the largest diameter of the nodule lies in the axial dimension.
Nodules 1, 2, and 4A had higher GI values for the manual method, while the
remaining nodules had higher GI values for the automated method. The large
GI values for the manual method on these nodules are likely due to asymmet-
ric growth of the nodule, which would be less likely to be captured correctly
by a single uni-dimensional measurement. Regions of interest around nodule
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(a) (b)
Figure 5.9: Region of interest of a single slice of the a) first scan and b) last scan
for nodule 1 showing asymmetric growth along the chest wall
1 on the first and last scans are shown in Figure 5.9 showing the asymmetric
growth of the nodule along the chest wall with very little growth perpendicular
to the chest wall. The higher GI values for the automated method on the other
three nodules was likely due to the increased sensitivity to change enabled by
the use of all of the three-dimensional data instead of making a single linear
measurement.
There is some deviation from the exponential growth model for all the nod-
ules, which could be due to either an actual change in the nodule growth rate or
sources of variation from the algorithm and data acquisition process. There is
some evidence for non-exponential tumor growth, such as Gompertzian growth
or a hybrid exponential and Gompertzian model [78], but in this case, we do not
know the “true” growth of the nodule and so are unable to verify whether these
deviations occur at the physiological level. Both the manual and automated
measurements show deviation from the exponential growth model, which sug-
gests that these deviations are not specific to either method.
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The process of acquiring the micro-CT scans from the live mice had sev-
eral sources of variation that may have affected the measurements from those
scans. As discussed in Section 5.1.1, not only were the micro-CT scans were not
well-calibrated from one scan to another, but there was overlap between the in-
tensity histograms of the lung parenchyma and soft tissue. These factors made
the placement of the boundary between the nodule and lung parenchyma diffi-
cult for both the human observer and the algorithm. In the automated method,
we used an adaptive threshold that was calculated in the same manner in every
scan, but any variations in this threshold would have resulted in an apparent
change in size beyond the actual nodule size change. Some of the variation
could be removed in future scans by performing more frequent scanner cali-
brations and including phantoms with known densities which could be used to
compensate for any drift in the scanner calibration.
The protocol required for scanning live mice may have also caused some of
the observed deviation from the exponential model. The shape of the lung was
different in each scan due to the respiratory gating equipment used in this study.
The respiratory gating was accomplished using a pressure sensor placed under
the mouse; when the mouse took a breath, pressure would be applied to the
sensor. This required external pressure to be applied to the mouse to ensure it
was snug against the sensor—this pressure altered the shape of the chest cavity
and may have compressed the lung. The mice also had more difficulty breath-
ing in later scans, due to the progression of disease. To measure this change
in the lung volume from scan to scan, the threshold found during the adaptive
thresholding step of the algorithm was used to segment the lung area. Morpho-
logical filtering and connected component analysis was performed to isolate the
lungs. We measured the lung volume in each scan for all the mice and found
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that the change from the maximum lung volume to the minimum lung volume
for a mouse ranged from 28% to 61%. This suggests that changes in the lung
volume and morphology due to changes in mouse positions and disease bur-
den may have contributed to variations in tumor volume measurements. This
source of variation could be eliminated in future studies by using a ventilator
to force the mouse to breathe at a fixed rate, ensuring that the lung is inflated to
the same volume each time and eliminating the external pressure on the mouse
for the pressure sensor.
5.6 Summary
In this study, we developed an automated pulmonary nodule segmentation al-
gorithm for measuring murine tumors imaged by micro-CT. This algorithm was
used to monitor the progression of six nodules in four mice. The growth of the
nodules show agreement with the exponential growth model; however, there
were deviations from a perfect exponential growth model, which may be due
to variations in the scan calibration and changes in the mouse lung volumes.
Nonetheless, the automated algorithm is able to carry out accurate measure-
ments of nodule volumes and can be used to monitor disease progression, en-
abling the use of nodule volume measurements from micro-CT as an imaging
biomarker in preclinical studies. In the future, this automated algorithm will be
evaluated with a larger cohort of animals and improved to handle nodules with
more difficult morphology. It can also be used to monitor disease progression
upon drug treatment and test potential therapeutic responses.
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CHAPTER 6
CONCLUSIONS
The primary goal of this dissertation was to improve the measurement of
pulmonary nodule growth rates CT scans to provide radiologists with better
information for making decisions regarding the follow-up and treatment of pa-
tients. The usefulness of growth rate measurements is limited by their uncer-
tainty due to errors and measurement variation—reducing these would allow
radiologists to quantify nodule growth earlier and improve patient outcomes.
A multifaceted approach was undertaken to advance the field of pulmonary
nodule growth rate measurement. The performance of current algorithms was
benchmarked against a common dataset for the first time. Two methods were
developed to reduce growth measurement variation, and a semi-automated
method was used to measure murine pulmonary nodule growth in micro-CT
scans. This work had the following novel contributions:
• A standard dataset of pulmonary nodules was made publicly available
and used to compare 18 different algorithms in the VOLCANO study [55].
• A moment-based method, ZCOMP, developed specifically to reduce the
impact of additional uncertainty in the z-direction of modern CT scan-
ners [62].
• A density-based nodule growth rate measurement method that improved
diagnostic accuracy, especially for nodules with complex shapes [61].
• A semi-automated method to measure murine pulmonary nodule growth
in micro-CT scans that was validated through comparison with the ex-
ponential growth model, allowing for growth rate measurement in pre-
clinical studies of small animals.
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6.1 VOLCANO study of algorithms on a standard dataset
Prior to the VOLCANO study [55], pulmonary nodule measurement algorithms
were evaluated on different datasets using different metrics, making compar-
isons between methods difficult. Furthermore, most evaluations were performed
using nodule size instead of nodule growth rate, which is the actual indicator
used for diagnosis. A dataset was created for the VOLCANO study with 49
nodules, including both zero-change and growing nodules, and a single phan-
tom, that was made publicly available. The growth rate results from eighteen
different methods were analyzed to identify trends amongst the methods.
The variability between methods was similar for those nodules imaged us-
ing the same slice thickness, but differed for nodules on different thickness
scans, implying that maintaining the same slice thickness is essential for re-
ducing measurement variability. The variation between the methods for the
zero-change nodules and those with change was similar, allowing zero-change
nodules to be used for measuring the variation of methods. Finally, although
the growth rate measurements were largely in agreement, the volume measure-
ments provided by twelve methods were not—these differing results indicate
that the results on volume can not be extrapolated to growth and vice versa.
6.2 ZCOMP method to address asymmetric growth in the z-
direction
During a review of zero-change nodules, some nodules were observed on a dif-
ferent number of CT scan slices between scans that were only minutes apart.
This additional variation in the z (axial) direction caused a bias in the growth
rate measurement which was not addressed by any previous methods. The
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ZCOMP algorithm [62] was developed to reduce the impact of any linear dis-
tortion in growth in the z-direction. The 3D image moments were calculated
from a binary segmented image and used to establish a surrogate volume mea-
surement. This ZCOMP method was evaluated on a dataset of 22 zero-change
nodules and compared to a semi-automated volumetric segmentation method.
Using ZCOMP, the variation was reduced from 95% limits of agreement of (-
52.1%, 30.1%) to (-34.2%, 23.3%) for nodules imaged on both same-slice thick-
ness and different-slice thickness scans.
6.3 Density-based growth rate measurement
The majority of nodule measurement algorithms segment the nodule from the
lung parenchyma and other attached structures; however, some nodules have
complex shapes and attachments that make explicit segmentation impossible.
These nodules also tend to be malignant, so measuring their growth rate is im-
portant. To measure these nodules, the growth index from density (GID) method
was developed [61]. The underlying idea of the GID method was that, as a nod-
ule grows, more cells are added, which should increase the density of the nod-
ule; thus, the change in density in a region of interest around the nodule was
used as a surrogate growth measure. In order to ensure the regions from one
scan to the next were as similar as possible, a rigid registration was performed
to align the two regions of interest.
On a dataset of 20 zero-change nodules, the GID method exhibited nearly
half the variation, (-19.7%,15.3%), of a volumetric segmentation method, (-54.6%,
30.3%). The diagnostic performance, measured on a dataset of 38 stable and 23
malignant nodules (4 of which were nodules with complex shapes), improved
from 74% correct for malignant nodules for the volumetric method to 96% for
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the GID method. Much of this improvement came from complex nodules that
were incorrectly segmented by the volumetric method.
6.4 Semi-automated growth measurement of murine pulmonary
nodules
While there have been many methods for measuring pulmonary nodule growth
for human pulmonary nodules, the methods available for murine pulmonary
nodule growth measurement are much cruder, requiring extensive manual in-
tervention. Murine models are extensively used in pre-clinical research, where
quantifying disease progression and treatment response are important. The
quality of micro-CT scans used in these pre-clinical study poses three main chal-
lenges: additional noise, lack of contrast between the lung parenchyma and
soft tissue, and poor calibration. A semi-automated volumetric method was
adapted to address these issues. One of the most significant changes was the
use of adaptive thresholding. In contrast to human CT scans, adaptive thresh-
olding was necessary to ensure accurate segmentation on micro-CT scans, due
to the shift in mean intensity cause by the poor calibration of the scanner, as well
as an overlap between the density histograms of the two tissue types. To evalu-
ate the method, instead of relying on manual measurements as truth, the nodule
growth rate was compared to the exponential growth model. Manual measure-
ments were also included and compared to the exponential growth model.
Six nodules from four mice were identified for this study. The semi-automated
method measured growth that was a better fit to the exponential model than
the manual method for five of the six nodules and only slightly worse for the
remaining nodule. This suggests that the semi-automated method was able to
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measure the murine pulmonary nodules better than manual measurements in
this study.
6.5 Future work
There are several logical extensions to the work presented here. The dataset
created for VOLCANO was successful in evaluating automated methods, but
including manual measurements by radiologists would allow for direct com-
parisons between automated and manual methods. Radiologist performance
and variation could be characterized in the different subgroups of nodules to
better understand the behavior of manual measurements in different situations.
Also, expanding the dataset to include nodules with known diagnoses would
allow for the evaluation of classification performance from growth rate mea-
surements.
There are many opportunities in pre-clinical studies for the development
and application of automated nodule measurement methods. Quantification of
the variation in volume and growth measurement is just as important an issue
in pre-clinical studies as with human patients—better measurements would en-
able earlier identification of disease or treatment response. The variation of both
manual and automated methods could be characterized. The preliminary work
on measuring murine pulmonary nodules could be extended to nodules in other
organs, such as the liver, in order to provide a reliable, non-manual method of
quantifying disease and treatment response for other forms of cancer.
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